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Zusammenfassung
Zwei lytische Pseudomonas aeruginosa spezifische Phagen mit weitem Wirtsspek-
trum, JG004 und JG024, wurden isoliert und charakterisiert. Beide Phagen gehören
zur Familie Myoviridae und erkennen das Lipopolysaccharid des Wirtes als Rezep-
tor. Die Dauer des Infektionszyklusses und das Wirtsspektrum wurden untersucht.
JG004 benötigt ungefähr 15 min um einen Infektionszyklus zu durchlaufen, Phage
JG024 benötigt ungefähr 25 min. Weiterhin können beide Phagen ein breites Spek-
trum unterschiedlicher P. aeruginosa Umwelt- und klinischer Isolate, sowie Stämme
mit einem mukoiden Phänotyp lysieren. Die Charakterisierung wurde mit der Se-
quenzierung beider Phagengenome vervollständigt. Phage JG004 zeigte nur geringe
Ähnlichkeiten zu bisher beschriebenen Phagen. Es konnte gezeigt werden, dass der
Phage von der Transkriptions- sowie DNA Replikationsmaschinerie des Wirtes unab-
hängig ist, aber auf die Spermidin Synthese des Wirtes angewiesen ist. Das Genom
von JG004 weist zwölf tRNAs auf, die offensichtlich für eine optimierte Translation
der Phagen mRNA benötigt werden. Phage JG024 wurde über den Genomvergleich
als ein neues Mitglied der PB1-ähnlichen Phagen identifiziert.
LPS-spezifische Phagen ermöglichen die Untersuchung verschiedener Fragestellung-
en zum bakteriellen LPS. In diesem Teil der Arbeit wurde die Rolle des verkürzten
LPS bei multiresistenten P. aeruginosa Stämmen untersucht. Ein Phagen-basiertes
in vitro System wurde etabliert, um P. aeruginosa Stämme mit verändertem LPS zu
identifizieren. Es wurde bewiesen, dass das verkürzte LPS aufgrund des Antibiotika-
stresses ensteht und zur Antibiotikatoleranz beiträgt, indem es die Toleranz gegen-
über oxidativem Stress erhöht. Mutationen in dem Gen PA5001, welches für eine
mögliche Glykosyltransferase codiert, konnten als Ursache für das verkürzte LPS
identifiziert werden. Charakterisierung einer P. aeruginosa PA5001 Deletionsmu-
tante bestätigte, dass die Verkürzung des LPS die Toleranz gegenüber oxidativem
Stress erhöht. Eine mögliche Beteiligung des Lipoproteins OprI an dem Mechanis-
mus der Stress Toleranz wurde diskutiert.
Diese Arbeit trägt dazu bei, die Biologie von P. aeruginosa spezifischen Phagen,
sowie Antiobiotika induzierte LPS Veränderungen in P. aeruginosa zu verstehen.
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Summary
Two new lytic Pseudomonas aeruginosa specific broad host range phages, JG004
and JG024, were isolated and characterized. Both phages belong to the family
Myoviridae and recognize the lipopolysaccharide layer as host receptor. The du-
ration of the infection cycle and the host range were determined. JG004 needs
approximately 15 min for one complete infection cycle, phage JG024 needs approxi-
mately 25 min. Both phages infect a broad variety of different P. aeruginosa strains,
isolated from the environment or clinic. Even strains with mucoid phenotype were
lysed by these phages. The characterization was completed by DNA sequence de-
termination of both phage genomes. Phage JG004 showed low similarities to other
already sequenced phages. This phage is independent from the host transcriptional
and DNA replication machinery but depends on spermidine synthesis of the host.
The JG004 genome encodes twelve tRNAs, most likely for the improvement of phage
mRNA translation. Phage JG024 was identified as a new member of the described
PB1-like phages.
LPS-specific phages are suitable tools for the investigation of various questions re-
garding bacterial LPS. In this study, we investigated the impact of truncated LPS
on antibiotic tolerance of multiresistant P. aeruginosa strains. A phage based in
vitro system was established to isolate and investigate P. aeruginosa strains with
variation in the LPS structure. We demonstrated that truncated LPS emerges as a
consequence of antibiotic stress. Modified LPS contributes to the antibiotic toler-
ance by enhacing the tolerance to oxidative stress. Moreover, we identified mutations
in the gene PA5001, a probable glycosyltransferase, as the cause for the LPS alter-
ations. A P. aeruginosa PA5001 deletion mutant was used to confirm our results
that truncation of the LPS leads to oxidative stress tolerance. The possible involve-
ment of the lipoprotein OprI in the mechanism of the stress tolerance was discussed.
In summary, this thesis contributes to the understanding of the biology of P. aeru-
ginosa specific phages and to antibiotic induced LPS alteration of P. aeruginosa.
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1 Introduction
1.1 General Phage Biology
Bacteriophages or phages in general are viruses that infect specifically bacteria.
Like other viruses they are obligate parasites using a host organism to multiply and
spread. A phage particle consists of a nucleic acid, DNA or RNA, which is enclosed
in a protein or lipoprotein coat. The envelope itself protects the genetic information
and is involved in the adsorption to the host (Guttman et al., 2005).
There are 17 officially accepted and 3 described families of prokaryotic viruses (Ack-
ermann, 2007) as shown in Table 1. Since there is no numerical taxonomy for
viruses the classification for phages is based on the morphology and the nature of
its nucleic acid (Clokie & Kropinski, 2009). Phages can have RNA or DNA, both
single stranded (ss) or double stranded (ds) whereas only two phage families exhibit
RNA as genetic material (Tab. 1).
The infection process starts with the adsorption of the phage to the host. Thereby,
the phage binds reversible to a specific surface structure on their target bacteria.
Typical receptors of Gram negative bacteria are the lipopolysaccharide, pili, flagella
and other surface proteins. In Gram positive bacteria the peptidoglycan, teichoic
and lipoteichoic acids as well as surface proteins are typical receptors for phages
(Guttman et al., 2005).
After the phage is irreversible attached to the host by binding to a second recep-
tor, the DNA is transferred directly into the bacterial cell by using an enzymatic
mechanism for penetrating the peptidoglycan and the inner membrane of the host
(Molineux, 2001; Roos et al., 2007). Once inside the cell the DNA has to be pro-
tected from host exonucleases and restriction enzymes. Common mechanisms for
protection is the circularization of the nucleic acid, inhibition of host nucleases or
using odd nucleotides like hydroxymethyldeoxyuridine (Arber & Dussoix, 1962; Dus-
soix & Arber, 1962; Kallen et al., 1962).
Then the phage promotors are recognized by the host RNA polymerase and early
genes will be transcribed. The gene products of these early genes are involved in
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Table 1: Overview of phage families. Derived from (Ackermann, 2007). *Awaiting classi-
fication.
Shape Nucleic Familiy Particulars Example
acid
Tailed DNA Myoviridae tail contractile T4
Siphoviridae tail long, nonconractile λ
Podoviridae tail short T7
Polyhedral DNA Microviridae conspicuous capsomers φX174
Corticoviridae complex capsid, lipids PM2
Tectiviridae inner lipid vesicle, pseudotail PRD1
SH1 inner lipid vesicle SH1
STV1 turret-shaped protrusions ST1V
RNA Leviviridae poliovirus-like MS2
Cystoviridae envelope, lipids φ6
Filamentous DNA Inoviridae a. long filaments fd
b. short rods MLV1
Lipothrixviridae envelope, lipids TTV1
Rudiviridae TMV-like SIRV-1
Pleomorphic DNA Plasmaviridae envelope, lipids, no capsid L2
Fuselloviridae same, lemon shaped SSV1
Salterprovirus same, lemon shaped His1
Guttaviridae droplet shaped SNDV
Ampullaviridae* bottle shaped ABV
Bicaudaviridae* two tailed, growth cycle ATV
Globuloviridae* paramyxovirus like PSV
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the host takeover. Host proteases, restriction enzymes and host biosyntheses are
inactivated before middle and late genes are transcribed. During the transcription
of middle and late genes, new phage particles are synthesized and assembled before
the bacterial cell bursts, induced by endolysins of the phage (Guttman et al., 2005).
This process describes the life cycle of a lytic phage (Fig. 1).
Figure 1: Types of viral life cycles (Weinbauer, 2004).
Lysogenic or temperate phages on the other hand can insert their genome into the
host genome. The phage is now called prophage and can coexist within the host.
Changes in the environment can lead to an induction of the prophage which will
induce the lytic life cycle. However, two other life cycles have to be mentioned.
Some phages can cause a chronic infection in bacteria. Thereby, the cell is infected
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by a phage and releases constantly phage progeny from the host by budding or
extrusion without lysing it. Moreover, some bacteria carry a plasmid-like prophage
which is also called persistent infection or pseudolysogeny (Fig. 1). In this state
phages multiply only in a fraction of the bacterial population (Weinbauer, 2004).
1.2 Importance of Bacteriophages Today
Since the discovery of bacteria specific viruses by William Twort (Twort, 1915) and
by Felix d’Herelle (d’Herelle, 1917) phage research is without doubt an important
part in biology. The research with bacteriophages resulted in important discoveries
as the identification of the genetic code and the DNA as genetic material and depicts
the first steps of molecular biology (Cairns et al., 1966). Moreover, phages and phage
derived products such as vectors, cosmids and promotors were important for the
development of recombinant DNA techniques. Other phage derived products like
integrases, DNA ligases and various other enzymes are an integral part of today’s
molecular biology (Summers, 2006).
After these great discoveries, phages were no longer in the focus of science. But
recently a new interest in phages emerged due to genome research and the emerging
antibiotic resistance of bacteria.
Genome research revealed that most bacteria carry lysogenic phages and that these
so-called prophages play an important role on the host genome evolution (Canchaya
et al., 2003; Brüssow et al., 2004). Also P. aeruginosa PAO1 carries three regions in
the genome which contain prophages. Two of these loci contain the so-called pyocins
which have an antimicrobial action. The region PA0610 to PA0648 is depicted as
R and F pyocin and unlike other pyocins they resemble the phage tails of P2 and
Lamda. The region PA0715-PA0729 has strong homologies to the phage Pf1. This
prophage is integrated in a gene which encodes for the glycin tRNA (Hayashi &
Nakayama, 2004).
More recently, new estimations about the diversity of phages and the impact of
these viruses on ecosystems are highly discussed (Abedon, 2009; Rohwer, 2003; Vos
et al., 2009). Besides, the upcoming antibiotic resistance of pathogenic bacteria also
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pushes the phages back into the spotlight. Researcher are forced to look for new
alternatives to treat these bacteria. An important aspect plays the nearly forgotten
phage therapy as a new "old" alternative to treat antibiotic resistant pathogens
(Skurnik & Strauch, 2006).
Some of the mentioned aspects will be discussed in more detail in the following
sections.
1.2.1 Global Diversity of Bacteriophages
Recent publications estimate about 6 million free living microbial species in the
world (Curtis et al., 2002). Moreover, it was shown that natural habitats like soil
and water contain 10 - 100 times more phages than bacteria (Clokie & Kropinski,
2009). But the abundance of phages varies in different environments and is related
to the abundance of the bacteria. Due to metagenome approaches it is estimated
that there are 1031 viruses on earth, most of them are viruses infecting bacteria since
bacteria are the most common prey items in the environment (Breitbart & Rohwer,
2005).
Phages are divided into families by morphology and nature of nucleic acid (1.1). Ack-
ermann (2007) pointed out that 96 % of the investigated phages belong to the tailed
phages and only the rest belong to the so-called pleomorphic, filamentous or polyhe-
dral phages. That means that most of the phages belong to the order Caudovirales.
There are three known phage families belonging to this order, Myoviridae, Siphoviri-
dae and Podoviridae. They all exhibit dsDNA as nucleic acid (Tab. 1).
In December 2009 554 complete genome sequences of phages were available, among
these sequences were 45 sequences of Pseudomonas specific phages (National Center
for Biotechnology Information). In addition, sequences from metagenomic approaches
of viruses were also published. Breitbart & Rohwer (2005) described that about
75 % of all sequenced genes did not match to any gene in databases, indicating that
most of the viral diversity is uncharacterized today. Moreover, it was evaluated that
there are about 100 million phage species in the world (Rohwer, 2003). On the other
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hand it was shown that certain conserved genes of phages were found in different
environments, suggesting that the local diversity is quite high but global diversity is
limited and that phages are moving between habitats (Breitbart et al., 2004). Also,
Ceyssens et al. (2009) showed that the Pseudomonas infecting PB1-like phages are
widespreaded in nature and very conserved. This supports the theory that global
virus diversity is limited.
Still, the genetic potential behind the phages and their impact on their hosts, the
bacteria, and hence to the environment should be immense and will be discussed in
the next section.
1.2.2 Influence of the Phage on the Bacterium and the Environment
Phages are an important genetic element in the evolution of bacteria since they
can transfer bacterial DNA from one to an other bacterium. This process is called
transduction which is a form of lateral gene transfer and is not exclusively species
specific, since some phages can infect more than one species. During an infection
process it happens that bacterial DNA is accidently packed into the new virion par-
ticle which is called generalized transduction. Specialized tranduction on the other
hand happens when a prophage removes itself incorrectly from the host DNA and a
part of the host DNA will be transferred via the progeny phages (Canchaya et al.,
2003).
Some phage genes encode for virulence factors which can increase the virulence of
a bacterium or convert their bacterial host from a non-pathogenic to a pathogenic
strain. This process is called lysogenic conversion (Waldor & Friedman, 2005).
For instance, Corynebacterium diphtheriae infects the upper respiratory tract and
causes inflammation and necrosis. The dreaded diphtheria toxin is only produced
when the bacterium carries the temperate phage β which encodes this protein (Free-
man, 1951). Moreover, some diarrhoegenic E. coli strains produce a group of related
toxins, the Shiga toxins, whose genes are part of the genome of lamboid prophages
(Herold et al., 2004). The phage φCTX was isolated from cytotoxin producing
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P. aeruginosa strains (Nakayama et al., 1999). The gene coding for the cytotoxin
is located on the genome of this phage. The cytotoxin makes P. aeruginosa more
virulent since the active cytotoxin makes holes in the cytoplasmic membrane of
eukaryotes. Other examples of lysogenic conversion comprise effects on proteins al-
tering antigenicity, effector proteins involved in invasion, different virulence related
enzymes and also effects on the adhesion of the bacterium to the eukaryotic host
(Brüssow et al., 2004).
Moreover, it was also shown that phages have an impact on the phenotypic variation
of P. aeruginosa. Rice et al. (2009) demonstrated that the filamentous prophage Pf4
is essential for several stages of the biofilm life cycle. Pf4 deficient mutants did not
undergo cell death and are less virulent. Genes encoding for prophages are also the
most upregulated genes during biofilm formation (Whiteley et al., 2001). But not
only biofilm variation also the emergence of small colony forming variants (SCVs)
seem to be dependent on the prophage (Webb et al., 2004). In addition, the pili-
dependent RNA phage PP7 drives morphological diversification in P. aeruginosa,
SCVs coexists with large colonies in a bacterial population when the phage is present.
Since all the depicted examples affect the bacterium itself the process of phages
killing bacteria have also a more global impact on ecosystems. Heldal & Bratbak
(1991) estimated that phages might kill 4-24 % of the bacterial population per hour
in aquatic systems and represents an important factor limiting bacterial popula-
tions. This shows that the viral community of an environment has a great impact
on microbial food web processes and on biogeochemical cycles (Weinbauer, 2004).
Bacteria are important for decomposition of other organisms as well as they con-
sume, produce and store nutrients. Lysis of bacteria makes nutrients available but
has also an impact on the biogeochemical pathways where bacteria are involved
(Abedon, 2006). It was published that viruses for example limit the primary pro-
ductivity of photosythetic bacteria in the ocean (Suttle, 1994). Moreover, phages
are an important biotic carbon pool and due to their high protein and DNA content,
phages may also contribute significantly to the biotic nitrogen and phosphorus pool
(Weinbauer, 2004).
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Also, the impact of phages on the bacteria of the human or animal flora were in-
vestigated. Most of published data refer to the occurence of bacteriophages in the
gastrointestinal contents of animals. It was shown that phage populations in intesti-
nal and rumenal microbial systems vary between species and individuals (Letarov
& Kulikov, 2009).
However, it was also demonstrated that phages were present in the lung of patients
with cystic fibrosis and active against P. aeruginosa (Brockhurst et al., 2005). At-
terbury et al. (2005) could show that the population of Campylobacter jejuni in
the intestine of chickens negatively correlates with the phage population. And it
was later presented by Scott et al. (2007) that these phages select for hosts with
large-scale genomic rearrangements that occur via lateral gene transfer.
1.2.3 Phage Therapy
Phage therapy has a long history. It started directly after the discovery of phages.
D’Herelle was convinced about the therapeutical potential of the phages due to their
specificity to bacteria and nontoxicity to animals and plants. In his first attempts
he treated dysentery patients successfully (Summers, 2001). Later in 1921 Joseph
Maisin used phages to treat staphylococci induced skin diseases (Sulakvelidze et al.,
2001). However, after the discovery of the first antibiotics in the western countries
phage therapy was forgotten, also because of the poorly investigated phage biology.
Only some countries in the former Soviet Union, especially the Elivia Institute in
Georgia, continued developing phages as a therapeutical agent (Summers, 2001).
Today after the worldwide emergence of antibiotic resistant pathogenic bacteria
phage therapy became again a possibility to treat bacterial infections. Advantages
over antibiotics are the specificity to certain bacteria and that phages can be isolated
and investigated rapidly. The upcoming of phage resistant bacteria can be easily
prevented by using phage cocktails (Sulakvelidze et al., 2001). Phages are non-
toxic and can be applied to surface infections without adverse effects as described
in Rhoads et al. (2009). On the other hand, the application of phages orally or
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intravenously is still highly discussed, because little is known about the reaction of
the immune system to the phages, the clearance of the phages in the body and the
actual effects on the infection.
But not only whole phages are used today. Some attempts showing that isolated
endolysins, the enzymes which helps the phage to free the progeny phages after a
complete lifecycle, can be used to treat infections of Gram positive bacteria (Fis-
chetti, 2005). Jado et al. (2003) used a phage encoded murein hydrolase to treat
Streptococcus pneumoniae infected mice. They suggest that phage lysins protect
animals from bacterial infections due to their results that the used murein hydrolase
rescued the infected mice in their study.
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1.3 Pseudomonas aeruginosa
1.3.1 The Bacterium Pseudomonas aeruginosa
Pseudomonas aeruginosa belongs to the group of free-living γ-proteo bacteria and is
ubiquitous in water and soil environments at a low frequency. It is a polar flagellated
rod (Fig. 2) with a high GC content of 68 % (Palleroni, 1992).
Figure 2: Electron microscopical picture of Pseudomonas aeruginosa. It has a length of
approximately 2 µm. The long thin structures in this picture are flagella whereas the
small round structures are membrane vesicles.
P. aeruginosa is able to produce several pigments like the green-fluorescent pigment
pyoverdin or the virulence related pigment pyocyanin which give cultures a charac-
teristic green-blue color (Palleroni, 1992).
The genome of P. aeruginosa PAO1 was published by Stover et al. (2000) and
depicts a large genome with a size of 6.3 Mbp and 5,570 predicted open reading
frames (ORF). 9.4 % of the ORFs encode for regulatory genes and two-component
systems. This leads to the suggestion that this bacterium is able to respond to
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different environments and changes within these environments. P. aeruginosa has a
high nutrient versatility and about 300 cytoplasmic transport systems (Stover et al.,
2000). The genome size of other sequenced P. aeruginosa strains varies in a range
from 5 - 7 Mbp suggesting adaptations to different environmental niches (Schmidt
et al., 1996).
It is facultative anaerob, prefers oxygen as the terminal electron acceptor and is
able to degrade various carbon sources, e.g. sugars, fatty acids, alcohols, glycols,
aromatic compounds, amines and also amino acids (Palleroni, 1992).
In contrast to the Enterobacteriaceae which degrade glucose via the Embden Meyer-
hoff Parnas pathway, P. aeruginosa uses the Entner Doudoroff pathway (KDPG-
pathway) although it favours the degradation of organic acids (Palleroni, 1992).
Under anaerobic conditions P. aeruginosa performs denitrification using nitrate or
nitrite as alternative electron acceptors. In the absence of a terminal electron accep-
tor P. aeruginosa fermentates the amino acid arginine (Wauven et al., 1984) as well
as pyruvate (Eschbach et al., 2004). Pyruvate fermentation supports only long-term
survival under anaerobic conditions but no growth.
Moreover, P. aeruginosa is able to form biofilms. Biofilms are structured communi-
ties of bacteria adherent to a surface and covered in a polymeric matrix (Costerton
et al., 1999). Biofilms are often involved in infections (see also next section). Due
to the nature of the biofilm antibodies of the host immune system, antimicrobials
and phages are nearly ineffective (Costerton et al., 1999).
1.3.2 Pathogenicity and Antimicrobial Resistance of Pseudomonas
aeruginosa
Additional to its high nutrient versatility and its appearance in different environ-
ments P. aeruginosa is also well known as an opportunistic pathogen for plants,
animals and humans using the same spectrum of virulence factors in all its hosts
(Rahme et al., 1995). This bacterium is related to many infections and diseases in
humans mainly in predisposed immunocompromised patients due to chemotherapy,
transplantations and HIV-infections (VanDelden & Iglewski, 1998). It can cause
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urinary tract, respiratory tract, ear, eye and burn wound infections. Respiratory
tract infections caused by P. aeruginosa are dreaded in patients suffering from Cys-
tic Fibrosis (Mucoviscidose) since these infections often cause the total loss of lung
function. Moreover, Tümmler & Kiewitz (1999) pointed out that P. aeruginosa is
an important nosocomial germ which belongs to the five most common pathogens
isolated in hospital-wide surveillance.
P. aeruginosa exhibits various resistance mechanisms towards antibiotics. The most
important mechanisms for the well known and dreaded innate antimicrobial re-
sistance are the low outer membrane permeability and the expression of several
multidrug eﬄux pumps (Schweizer, 2003). The permeability of the outer membrane
in P. aeruginosa is even lower than in Escherichia coli (Yoshimura & Nikaido,
1982). Chromosomally-encoded eﬄux systems transport not only antibiotics but
also structurally distinct classes of biocides, dyes, detergents and even quorum
sensing molecules across the membranes (Schweizer, 2003). The asymmetric bi-
layer of the outer membrane with its variable lipopolysaccharide (LPS) serves as an
effective barrier against the rapid penetration of lipophilic antimicrobials (Nikaido,
1994; Poole, 2002) and completes the innate resistance of this clinical important
species. Moreover, the biofilm lifestyle of P. aeruginosa serves also as a mechanism
of resistance, since the biofilm restricts the diffusion of the antibiotic and also re-
duces the growth rate, which makes most of the antimicrobial agents less effective
(Drenkard, 2003).
P. aeruginosa expresses five different multidrug eﬄux systems (Mex) which promote
multidrug resistance due to hyperexpression of the eﬄux genes (Schweizer, 2003).
These eﬄux pumps belong to the RND (resistance nodulation devision) familiy of
eﬄux pumps and have a tripartite system. They are driven by the proton motive
force and consist of a transporter protein which is located in the inner membrane,
an outer membrane protein and a accesory protein which is located in the periplasm
(Piddock, 2006).
It was shown that treatment of P. aeruginosa with antibiotics leads to mutations in
the gene mexR (Ziha-Zarifi et al., 1999). MexR is the negative regulator of the mex-
ABoprM eﬄux operon and belongs to the MarR family of transcriptional regulators
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(Poole et al., 1996). Besides MexR, this eﬄux pump is also regulated by two other
negative regulators, NalC (Cao et al., 2004) and NalD (Morita et al., 2006). More-
over, it is suggested that this eﬄux pump has also a role in the pathogenesis of P.
aeruginosa since strains lacking this eﬄux pump were not able to infect leukocyte
deficient mice in contrast to the wild type (Hirakata et al., 2002).
Recently, a proposed model for the mechanism of the MexR-regulated antibiotic re-
sistance was published. Chen et al. (2008) showed that the MexR regulator exhibits
two redox-active cystein residues which enables the regulator to sense oxidative stress
in the cell. This oxidative stress in the cell could be triggered by antibiotics which
stimulate the hydroxyl radical formation via the Fenton reaction (Kohanski et al.,
2007). Moreover, oxidative stress induced by antibiotics or the leukocytes during
infection might also be involved in the development of resistance due to oxidative
DNA damage in the cell (Mandsberg et al., 2009).
1.3.3 The Lipopolysaccharide (LPS) of Pseudomonas aeruginosa
The LPS of P. aeruginosa is an important virulence factor on the outer leaflet of
the outer membrane. The LPS structure of P. aeruginosa is similar to the LPS of
other Gram negative bacteria and consists of three domains: the lipid A, the core
oligosaccharide and the O polysaccharides. It is a physical barrier, can mediate
direct interaction with the host and, as an endotoxin, damages host tissues (King
et al., 2009).
The lipid A anchors the LPS to the outer membrane. It consists of fatty acids
which are attached to doubly-phosphorylated diglucosamines. Most strains show a
penta- or hexa-acylated form (King et al., 2009). The lipid A is responsible for the
toxicity of Gram negative bacteria because this part of the LPS is recognized by the
TLR4 (toll-like receptor 4) receptor complex in humans which activates the immune
system. But the lipid A of P. aeruginosa is significantly less toxic than the lipid A
of enteric bacteria like E. coli due to the length and number of acyl chains (Bäckhed
et al., 2003).
The core oligosaccharide is directly attached to the lipid A and can be divided into
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the inner and outer core. The inner core consists of two 3-deoxy-D-manno-oct-2-
ulosonic acid (Kdo) and two heptose residues which serve as the phosphorylation
site (Fig. 3). One Kdo is linked to one glucosamine of the lipid A. The outer core has
three different sugar types: glucose, rhamnose and galactoseamine. P. aeruginosa
can produce two glycoforms of the LPS simultaneously (Fig. 3). Both glycoforms
share the same inner core structures but the glycoform 1 is never substituted by
O-antigen (King et al., 2009).
Figure 3: LPS structure and the comparison of the two glycoforms of the LPS core (King
et al., 2009). Genes involved or putatively involved (*) in enzymatic steps are indicated.
Ala, alanine; Cm, carbamoyl; Etn, ethanolamine; GalN, 2-amino-2-deoxy-galactose; Glc,
glucose; Hep, L-glycero-D-manno-heptose; Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid;
Rha, rhamnose.
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Due to their O specific antigen P. aeruginosa strains can be divided into serogroups.
Currently, there are 20 different serogroups of P. aeruginosa (Liu & Wang, 1990).
The O specific antigen itself consists of sugar repeats with different constitution.
Moreover, Rivera et al. (1992) pointet out that many P. aeruginosa strains carry
a second LPS species which is called common O polysaccharide and is a rhamnan
homopolymer. In some publications the O specific antigen is called B-band LPS
whereas the common O polysaccharide is described as A-band LPS.
There are several examples that the LPS of P. aeruginosa could have an impact on
the resistance of this bacterium. Mutations which lead to changes in the LPS pro-
file of P. aeruginosa when treated with antibiotics like ciprofloxacin (Legakis et al.,
1989), gentamicin (Bryan et al., 1984; Shearer & Legakis, 1985) and also carbeni-
cillin (Godfrey et al., 1984; Shearer & Legakis, 1985) were reported. These studies
have in common that the alteration of the LPS contributes to the antibiotic resis-
tance, suggesting that the altered LPS may impair the uptake of the antimicrobial
compound.
Moreover, it was also shown that the phosphate residues of the core LPS play an
important role in the intrinsic resistance of P. aeruginosa. Walsh et al. (2000)
showed that additional phosphate residues can lead to an increase of antimicrobial
resistance. Also, Schurek et al. (2008) showed that aminoglycoside resistance in
P. aeruginosa is a product of several variable mechanisms and that LPS mutants
had a reduced susceptibility to tobramicin.
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1.4 Aims of the Study
The aim of this study was divided into two parts. In the first part Pseudomonas
aeruginosa specific phages had to be isolated and characterized. In this context, the
host receptor, the host spectrum, the burst size and the duration of the infection
cycle were of interest. Moreover, DNA sequence analysis of the corresponding
genomes and comparison to known phage genomes were envisaged.
Successful isolated lipopolysaccaride specific phages should be used in a second part
of this thesis as a screening tool for the investigation and isolation of P. aeruginosa
strains with truncated LPS. We were interested if the truncated LPS contributes
to antibiotic tolerance of P. aeruginosa and if bacteriophages are suitable tools for
these investigations. To monitor the emergence of P. aeruginosa strains with an
truncated LPS during antibiotic stress, a phage based in vitro system had to be
developed. Using this phage based in vitro system, the exact role of the truncated
LPS in antibiotic resistance as well as the mutation causing this phenotype should
be elucidated.
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2.1 Instruments and Chemicals
2.1.1 Instruments
Agarose gel electrophoresis Agagel (Biometra)
Agarose gel documentation GelDoc (Bio-Rad)
Autoclave EL3850 (Systec)
Biological Safety Cabinet HeraSafe (Heraeus)
Centrifuges Minispin (Eppendorf)
Biofuge fresco (Heraeus)
Megafuge 1.0 R (Heraeus)
DNA sequencing Genetic Analyzer ABI PrismTM (Applied
Biosystems)
Incubator Fine Line (Heraeus)
Thermo Shaker PST-60 HL-4 (Lab4You)
Aquatron (Infors)
pH determination Microprocessor pH Meter 211
Photometer Ultrospec (Amersham Biosciences)
SDS-PAGE system MiniProtean II (Bio-Rad)
Spectrophotometer Nanodrop ND-1000-UV/VIS (PEQLAB)
Thermocycler Tpersonal (Biometra)
Tgradient (Biometra)
Thermomixer Thermomixer compact (Eppendorf)
Vortex Vortex Genie 2 (Scientific Industries)
Water purification MilliQ System
Weighing machine 572 (Kern & Sohn)
ALJ 160-4NM (Kern & Sohn)
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2.1.2 Chemicals and Kits
Chemicals and reagents not specifically listed here were purchased from the following
manufacturers: Amersham Biosciences, Fluka, Merck, Roth, Sigma-Aldrich, Riedel-
de-Häen.
5-aminolevulinic acid Sigma
Benzonase Nuclease Novagen
GeneRulerTM DNA Ladder Mix MBI Fermentas
Oligonucleotides Metabion
Primer Metabion
Proteinase K Sigma-Aldrich
QIAquick Gel Extraction Kit Qiagen
QIAquick PCR Purification Kit Qiagen
Restriction Endonucleases New England Biolabs INC
SAP (Shrimp Alkaline Phosphatase) MBI Fermentas
T4 DNA ligase New England Biolabs INC
Taq DNA Polymerase GE Healthcare
2.2 Bacteria, Phages and Plasmids
All phages, bacterial strains and plasmids used for this work are listed in Table 2,
Table 3, Table 4 and Table 5.
Table 2: List of Bacteriophages
Plasmid Description Reference
JG004 P. aeruginosa PAO1 bacteriophage This work
JG024 P. aeruginosa PA14 bacteriophage This work
SZ06 P. aeruginosa PAO1 TM5 bacteriophage This work
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Table 3: List of Plasmids
Plasmid Description Reference
pEX18Ap Apr; oriT+ sacB+ Hoang et al. (1998)
pFLP2 Apr; Flp coding plasmid Hoang et al. (1998)
pPS858 Apr; Gmr Hoang et al. (1998)
pJG002 Apr Gmr; pEX18Ap with 501 bp upstream
mexR, Gmr-gfp fragment from pPS858, and
432 bp downstream of the coding region of
mexR between SacI and HindIII
This work
pJG005 Apr Gmr; pEX18Ap with 386 bp upstream
PA5001, Gmr-gfp fragment from pPS858,
and 500 bp downstream of the coding
region of PA5001 between SacI and HindIII
This work
pUCP20T mobilizable E. coli - P. aeruginosa shuttle
vector; Cbr
Schweizer et al.
(1996)
pJG004 pUCP20T with coding region of PA5001
between XbaI and Kpn; Cbr
this work
pBT20 Mini-TnM delivery vector, AprGmr Kulasekara et al.
(2005)
pLAFR3 Tcr, broad host range cosmid Staskawicz et al.
(1987)
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Table 4: List of Escherichia coli strains
Strain Description Reference
DH10B F- mcrA ∆(mrr-hsdRMS-mcrBC ) 80 lacZ
∆M15 ∆lacX 74 deoR recA1 endA1 araD
∆(ara, leu)
Invitrogen
ST18 pro thi hsdR+ Tpr Smr; chromosome::RP4-2
Tc::Mu-Kan::Tn7/λpir ∆hemA
Thoma & Schobert
(2009)
S17λpir pro thi hsdR+ Tpr Smr; chromosome::RP4-2
Tc::Mu-Kan::Tn7/λpir
de Lorenzo & Tim-
mis (1994)
Table 5: List of Pseudomonas aeruginosa strains
Strain Description Reference
PAO1 wild type Dunn & Holloway (1971)
PA14 wild type Rahme et al. (1995)
JG01 PAO1∆algC Julia Garbe, unpublished
TM5 PAO1 transposon mutant This work
TM6 PAO1 transposon mutant This work
PAO1 DK wild type Klausen et al. (2003)
PAO1 DK pilA PAO1 DK ∆pilA Klausen et al. (2003)
PAO1 DK fliM PAO1 DK ∆fliM Klausen et al. (2003)
JG09 PAO1∆mexR This work
JG94 PAO1∆PA5001 This work
JG95 PAO1∆mexR ∆PA5001 This work
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Strain Description Reference
GH06 41910 clinical isolate Michael Hogardt, München
GH06 54733-2 clinical isolate Michael Hogardt, München
GH06 21466 clinical isolate Michael Hogardt, München
GH06 25135 clinical isolate Michael Hogardt, München
GH06 20934 clinical isolate Michael Hogardt, München
BT2 clinical CF isolate MHH
BT72 clinical CF isolate MHH
BT73 clinical CF isolate MHH
RN3 clinical CF isolate MHH
NN84 clinical CF isolate MHH
PACF15 clinical CF isolate Gerd Döring, Tübingen
PACF21 clinical CF isolate Gerd Döring, Tübingen
PAKL1 clinical CF isolate Gerd Döring, Tübingen
PAKL4 clinical CF isolate Gerd Döring, Tübingen
PACF60 clinical CF isolate Gerd Döring, Tübingen
PACF61 clinical CF isolate Gerd Döring, Tübingen
PACF62 clinical CF isolate Gerd Döring, Tübingen
PACF63 clinical CF isolate Gerd Döring, Tübingen
MH 18 clinical urinary tract isolate Michael Hogardt, München
MH 19 clinical urinary tract isolate Michael Hogardt, München
MH 26 clinical urinary tract isolate Michael Hogardt, München
MH 29 clinical urinary tract isolate Michael Hogardt, München
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2.3 Buffers
Frequently used buffers:
Tris Acetate EDTA (TAE) buffer: 40 mM Tris-acetate
1 mM EDTA
in dH2O, pH 8.0
Phosphate buffered Saline (PBS) buffer: 137 mM NaCl
2.7 mM KCl
10 mM Na2HPO4
2 mM KH2PO4
in dH2O
SM buffer: 100 mM NaCl
8 mM MgSO4
50 mM Tris-HCl
in dH2O, pH 7.5
2.4 Media and Media Additives
2.4.1 Growth Media
Luria-Bertani (LB) medium was used as a standard komplex medium for growth of
P. aeruginosa and E. coli. The composition is based on the protocoll of Sambrook
(1989)
LB medium: 1 % (w/v) trypton
0.5 % (w/v) yeast extract
0.5 % (w/v) NaCl
in dH2O
For LB agar plates 15 g/l agar was added to the medium.
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2.4.2 Media Additives
Concentrated stock solutions of media additives like sucrose, ALA and antibiotics
were prepared and sterilized by filtration (pore width 0.2 µm). Additives were
dissolved in MilliQ water, except for chloramphenicol and tetracycline. Chloram-
phenicol was dissolved in 100 % ethanol and tetracycline as well as levofloxacin in
50 % ethanol. Concentrations for stock solutions and final concentrations are listed
in Table 6. MIC indicates that the antibiotics were used in different concentrations
as described in 2.5.8 (MIC: minimal inhibitory concentration).
Table 6: Media Additives
Substance Stock solution Concentration for Concentration for
P. aeruginosa E. coli
Carbenicillin 100 mg/ml 500 µg/ml/MIC 100 µg/ml
Gentamicin 30 mg/ml 80 µg/ml 10 µg/ml
Chloramphenicol 100 mg/ml - 10 µg/ml
Tetracycline 5 mg/ml 80 µg/ml 5 µg/ml
Levofloxacin 20 mg/ml MIC -
Nalidixic Acid 5 mg/ml MIC -
ALA 50 mg/ml - 50 µg/ml
2.5 Microbiological Techniques
2.5.1 Sterilization
All media were autoclaved at 121 ℃ and 1 bar positive pressure for 20 min. Other
substances and solutions were either autoclaved or, if temperature sensitive, steril-
ized by filtration (pore width 0.2 µm).
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2.5.2 General Growth Condition
Aerobic cultured bacteria were incubated in Erlenmeyer flasks at 37 ℃ and 200 rpm
(Aquatron). The incubation time depended on the experiment and is indicated.
E. coli ST18 was always grown in the presence of 50 µg/ml aminolevulinic acid
(ALA) since this strain is hemA deficient and can not synthesize ALA.
2.5.3 Determination of Cell Density
The cell density of liquid cultures was determined by measuring the optical density
(OD) at a wavelength of 578 nm. An OD578 of 1.0 corresponds to approximately
1 x 109 cells/ml.
2.5.4 Determination of Colony Forming Units
The colony forming unit was determined by diluting an aseptic taken sample in PBS
buffer. Appropiate dilutions were plated on LB agar plates and incubated for 16 to
24 h at 37 ℃. Afterwards the visible colonies were counted and the colony forming
unit per ml was calculated.
2.5.5 Storage of Bacterial Strains
Glycerol stocks were prepared for long-term storage. For this 850 µl of overnight
cultures were mixed with 150 µl of sterile glycerol (15 %). Stocks were frozen and
kept at -80 ℃.
2.5.6 Determination of Minimal Inhibitory Concentrations (MIC)
The minimal inhibitory concentration (MIC) was determined in 96 well plates.
105 cells per ml of an overnight culture were inoculated in LB with appropriate
concentrations of antibiotics, H2O2 or menadione. The overnight culture was grown
in the same medium at 37 ℃ and 200 rpm for 12 h. 96 well plates were then in-
cubated at 37 ℃ in a microplate incubator for 20 h. MICs were estimated as the
lowest concentration of antibiotics which inhibited growth.
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2.5.7 Antibiotic Susceptibility Test
Antibiotic susceptibility tests stribes ATBTM PSE I were purchased from Bio-Mérieux
and used according to manufacturer’s instructions. Each strain were tested in dubli-
cate. Antibiotic susceptibility was categorized as sensitive (no growth), intermediate
(growth in the presence of low antibiotic concentrations) and resistant (growth in
the presence of high antibiotic concentrations).
2.5.8 Menadione Survival Assay
To test the tolerance to oxidative stress, menadione was used as a superoxide radical
producer. Cells of an overnight culture were pelleted and resuspended in PBS buffer
to an OD578 of 0.1. Menadione sodium bisulfite (Sigma-Aldrich) was added in various
concentrations ranging from 2.5 mg/ml to 10 mg/ml and the cells were incubated
at 37 ℃ for 4 h. After incubation aseptic taken samples were diluted in PBS buffer
and plated on LB agar plates. Before bacterial enumeration and determining the
CFU (2.5.4) the LB agar plates were incubated for 12 to 24 h at 37 ℃.
2.5.9 Phage Isolation
Phages were isolated from sewage following a simple enrichment procedure. Samples
from sewage were centrifuged for 5 min at 4100 x g (Biofuge fresco). Ten ml of
the supernatant were mixed with 5 ml of an P. aeruginosa overnight culture and
incubated in 50 ml LB broth at room temperature. After an incubation of 48 h the
cells were sedimented by centrifugation at 4100 x g (Biofuge fresco) for 10 min and
the supernatant was transferred to a clean tube. To kill the remaining bacteria,
several drops of chloroform were added to the supernatant and the mixture was
mixed for 30 s. To separate the phages, appropriate dilutions of the phage lysate
were spotted onto bacterial lawns of top-agar plates. Top-agar plates were produced
by adding approximately 5 x 108 cells/ml of P. aeruginosa from an overnight LB
broth to 3.5 ml of LB top agar (0.75 %). The inoculated top-agar was overlaid on
an LB agar plate and allowed to solidify. After incubation at 37 ℃ for 10 to 16 h
zones of lysis were recognized. Single plaques, derived from a single phage, were
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separated by stinging with a pipette tip into the plaque followed by resuspending
the phages in SM buffer. The resulting phage lysate was stored at 4 ℃.
2.5.10 Propagation of Phages
To propagate phages top-agar plates were prepared as described in 2.5.9. Addi-
tionally, 100 µl of a phage lysate was added to the top-agar. After 12 to 16 h of
incubation at 37℃ lysis of the bacteria were recognized and the plates were overlaid
with 10 ml of SM buffer. This was followed by 4 h incubation at 4 ℃ to dissolve the
phages from the top-agar. The SM buffer enriched with the phages was removed
from the plates and centrifuged for 10 min at 4 ℃ and 4100 x g (Biofuge fresco)
to pellet the remaining bacteria. The supernatant was sterilized by filtration (pore
width 0.2 µm) and the phage titer of the phage stock was measured.
2.5.11 Determination of Phage titer
The phage titer was determined by diluting a phage solution in SM buffer. Ap-
propiate dilutions were spotted on a top-agar plate (2.5.9) with the appropiate host.
After incubation for 12 to 16 h at 37 ℃ the plaques derived from single phages were
counted and the plaque forming unit per ml was calculated.
2.5.12 Storage of Phages
For long-term storage of phages glycerol stocks were prepared. Therefore, 850 µl of
a phage stock (2.5.10) was mixed with 150 µl of sterile glycerol (15 %). Stocks were
frozen and kept at -80 ℃.
2.5.13 Phage Host Range Determination
To determine the phage host range, top-agar plates (2.5.9) with the potential host
lawn were prepared. Ten µl of a phage stock solution were spotted on the top-agar
plate and incubated at 37 ℃ for 12 to 16 h. After incubation, the appearance of
the lysis zones at the site where the phage suspension was added, were examined.
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Each phage was tested against each bacterial strain in triplicate in independent
experiments. The lysis was catergorized as clear (+), turbid (0) and no reaction (-).
2.5.14 Electron Microscopy
Electron microscopy was performed by Dr. Manfred Rohde from the Helmholtz
Centre for Infection Research (HZI). A phagetiter of 108 phages/ml was used.
2.5.15 Phage Growth Characteristics
To determine phage growth characteristics like the burst size and the duration of
the infection cycle, single step growth experiments were performed as described in
Pajunen et al. (2000). P. aeruginosa was grown aerobically in 20 ml LB medium
till exponential growth phase (2.5.2). After the bacteria reached an OD578 of 0.3
an amount of 109 phages were added to the culture. Samples for OD measurement
(2.5.3) to follow bacterial growth and samples for the determination of phage enu-
meration were taken aseptic at different time points after infection (0 min, 5 min, 10
min, 15 min, 20 min, 25 min, 30 min, 40 min, 60 min). To determine the phagetiter
as described in 2.5.11 100 µl of an aseptic taken sample were centrifuged to pellet
the bacteria in the sample and then diluted in SM buffer.
Burst Size
The burst size indicates the average number of phage progeny per infected cell at
the end of one infection cycle. To calculate the burst size, the number of phages at
the plateau of the sigmoidal curve was divided by the number of phages before the
exponential growth begins (Carlson, 2005).
Duration of Infection Cycle
The duration of the infection cycle is described by the latent phase of the phage. In a
single step growth curve at the end of the latent phase the amount of phages suddenly
rises which describes the endpoint of the infection cycle because the progeny phages
are released at this time point.
29
2 Materials and Methods
2.5.16 Phage Based in vitro System to Screen for LPS Variants
Screening of the transposon mutants is described in 2.6.7. To determine whether
the LPS alterations in the mexR deletion mutant occur during antibiotic exposure
the following method was used. An overnight culture of JG09 with and without
carbenicillin (200 µg/ml) was serially inoculated over a period of 6 days. Each day
1 x 108 cells were incubated with a tenfold excess of bacteriophage JG004 for 1 h at
37 ℃. After incubation the colony forming units (2.5.4) of the phage resistant cells
were determined. The colony forming unit of the cultures without exposure to the
bacteriophage JG004 was also determined to calculate the exact number of phage
resistant cells (2.5.4). The naturally occurence of phage JG004 resistant bacteria
was determined as below 0.012 %. To determine this rate, the wild type PAO1 was
incubated with the phage JG004 as described above in LB without antibiotics. The
result indicate that phage JG004 is an applicable tool to screen for LPS alterations.
To induce or prevent oxidative stress we used LB medium without bivalent ions us-
ing Chelex® 100 resin (Bio-Rad) following the manufactures instructions. Ferrous
iron contributes to the Fenton reaction and therefore to hydroxyl radical formation
whereas medium without ferrous iron prevents this formation. Trace metals (1 ml/l),
magnesiumchlorid (1 mM) and calciumchlorid (100 µM) were added to the medium
after Chelex treatment to permit growth of the bacteria. To induce oxidative stress
by enforcing the Fenton reaction, 1 mM ferrous sulfate was added to the medium.
Trace metals: 200 mg CaSO4 * 2 H2O
200 mg FeSO4 * 7 H2O
20 mg MnSO4 * H2O
20 mg CuSO4 * 5 H2O
20 mg ZnSO4 * 7 H2O
10 mg NaMoO4 * H2O
5 mg H3BO3
in 1 l dH2O
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2.5.17 Reactive Oxygen Species (ROS) Assay of P. aeruginosa
To determine the reactive oxygen species in single cells a culture of P. aeruginosa
was grown aerobically in LB at 37 ℃ till early exponential phase. The growth was
monitored by measuring the optical density (2.5.3). After the culture reached an
OD578 of 0.4 antibiotics like carbenicllin (200 µg/ml) and gentamicin (5 µg/ml) or
as a control the superoxid radical producer menadione (10 mg/ml) were added and
followed by an incubation of 1h at 37 ℃. Finally the cells were diluted in PBS to an
OD 0.5 and incubated with the flourescence dye H2DCFDA (Invitrogen) according to
manufacturer‘s instructions. The resulting flourescence of single cells was measured
by flourescence activated cell sorting.
2.6 Molecular Biology Techniques
2.6.1 Polymerase Chain Reaction
The colony PCR (Polymerase chain reaction) technique was used to amplify genes
directly from the P. aeruginosa genome. As DNA template a single P. aeruginosa
colony from an agar plate was isolated, resuspended in sterile destilled water and
mixed. Taq DNA polymerase (GE healthcare) was used for all reactions.
For a 50 µl PCR reaction 1 µl of the DNA template, 5 µl 10 x PCR-buffer, 10 pmol
Primer, 200 µm dNTPs, 0.5 Units Taq DNA polymerase and 3 % (v/v) DMSO was
mixed. The first denaturation step at 95 ℃ for 5 min was followed by a cycle of
denaturation, primer annealing and elongation. This cycle was completed 30 times
and the syntheses was finished after 5 min at 72 ℃. The denaturation at 95 ℃ for
1 min and the elongation temperature of 72℃ remained unchanged. The elongation
time was chosen according to the length of the PCR fragment to be amplified. Taq
DNA polymerase used in this work synthesizes approximately 1 kb in 1 min. The
annealing temperature depended on oligonucleotide length and G+C content and
was determined in a gradient cycler.
All PCR products were purified using the QIAquick PCR Purification Kit according
to manufacturer‘s instructions.
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2.6.2 Electrophoretic Separation of DNA
For the analytical separation of DNA fragments, 1 % (w/v in TAE buffer) agarose
gels were prepared. Prior to use the DNA fragments were mixed with loading dye
and the GeneRulerTM DNA Ladder Mix was used as a size standard according to
the manufacturer’s instructions. A voltage of 100 V was applied to the loaded
gels. After electrophoresis the gels were incubated in an ethidium bromide solu-
tion (0.1 % (v/v)) for 10-20 min to visualize the seperated DNA fragments under
UV light (λ = 312 nm). If extraction of the DNA fragments was required the ex-
traction was carried out using the QIAquick Gel Extraction Kit according to the
manufacturer’s instructions.
2.6.3 Enzymatic Modification of DNA
Restriction of DNA with Restrictionendonucleases
The restriction of DNA was carried out using restriction endonucleases and buffers
purchased from NewEngland Biolabs. Conditions and buffers were chosen according
to the manufacturer’s instructions. The incubation time for the restriction was 2
to 4 h. Finally the digested PCR products or plasmids were purified using the
QIAquick PCR Purification Kit according to manufacturer‘s instructions. Digested
phage DNA was directly applied to a agarose gel and seperated (2.6.2).
Ligation
For ligation of DNA the T4 DNA ligase (NewEngland Biolabs) according to manu-
facturer‘s instructions was used. If necessary the 5’ phosphate groups were removed
to avoid re-circularization of the vector. Therefore 3.5 U of shrimp alkaline phos-
phatase (NewEngland Biolabs) was added to the vector and incubated at 37 ℃ for
15 min. After 15 min heat activation at 65 ℃ the vector was purified using the
QIAquick PCR Purification Kit according to manufacturer‘s instructions. The lig-
ation was carried out using an amount of 100 ng vector DNA mixed with the insert
DNA in excess, in which a molar ratio of 1:3 was used. Finally, the ligation was
incubated at 20 ℃ for 2-5 h.
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2.6.4 Transformation of Escherichia coli using CaCl2 competent cells
E. coli DH10B or ST18 were grown aerobically in 100 ml LB at 37 ℃ and 200 rpm.
The growth was monitored by measuring the OD578. Starting at an OD578 of 0.05
the cells were grown till the culture reached an OD578 of 0.6 to 0.7. The culture
was chilled on ice for 10 min before harvesting the cells by centrifugation (10 min,
4,000 rpm, Megafuge 1.0 R). The pellet was resuspended in 10 ml of ice cold CaCl2
buffer and again centrifuged as described above. The supernatant was discarded
and the cells resuspended in 1 ml of CaCl2 buffer. 50 µl aliquots were prepared,
either immediately used for transformation or stored at -80 ℃.
For transformation of E. coli by heat shock the competent cells were first thawed
on ice for 15 min and than mixed with 10 - 50 ng of plasmid DNA. After incubation
on ice for another 20 min the cells were subjected to a heat shock by incubation
at 42 ℃ for 45 sec. Afterwards 400 µl fresh LB were added for the recovery of the
cells. After incubation at 37 ℃ for 30 to 60 min different volumes were streaked
on LB agar plates containing the appropiate antibiotics and plates were incubated
overnight at 37 ℃.
CaCl2 buffer: 100 mM CaCl2
10 % glycerin
in dH2O
2.6.5 Preparation of Plasmid DNA
To prepare the plasmid DNA the alkaline lysis method described in Sambrook (1989)
was used. 4 ml of an overnight culture was harvested by centrifugation for 2 min
at 4 ℃ (13,000 rpm, Heraeus Biofuge fresco). The pellet was resuspended in 300 µl
buffer P1. After addition of 300 µl buffer P2 the sample was carefully mixed by in-
verting and incubated at RT for 5 min. Next 300 µl of buffer P3 were added, again
carefully mixed by inverting and incubated for 5 min at RT. After centrifugation
for 20 min at 4 ℃ (13,000 rpm, Heraeus Biofuge fresco) 800 µl of the supernatant
was mixed with 0.7 volumes of isopropanol and incubated for 10 min at RT. The
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precipitated plasmid DNA was centrifuged for 15 min (13.000 rpm, 4 ℃, Heraeus
Biofuge fresco) before washing with 70 % ethanol. After all traces of ethanol had
evaporated, the DNA was solubilized in 50 µl dH2O and stored at -20 ℃.
P1: 50 mM Glucose
25 mM Tris HCl, pH 8.0
10 mM EDTA, pH 8.0
in dH2O
P2: 0.2 N NaOH
1 % SDS
in dH2O
P3: 3 M Na Acetat, pH 5.3
in dH2O
2.6.6 Diparental Mating of Pseudomonas aeruginosa
The E. coli strains ST18 (Thoma & Schobert, 2009) contains the tra-genes which
are necessary for conjugation. Thereby it is possible to transfer a plasmid from
E. coli ST18 to P. aeruginosa via conjugation. Moreover, the strain ST18 contains
a hemA deletion resulting in a defective tetrapyrrole biosynthesis. This mutation is
of great advantage since counterselection of the E. coli donor strain is not required
(Thoma & Schobert, 2009).
Overnight cultures of the donor strain E. coli ST18 and the recipient P. aeruginosa
were made. For the diparental mating 1 ml of the E. coli ST18 culture was mixed
with 100 µl of the P. aeruginosa culture and centrifuged for 1 min at 13,000 rpm (Ep-
pendorf MiniSpin). The cells were resuspended in 100 µl LB medium and dropped
on an agar plate, dried for 30 min and finally incubated for 6 h at 37 ℃. During this
time the mobilizable plasmid is transferred from E. coli ST18 to P. aeruginosa.
Afterwards the cells were taken off the LB agar plate and were resuspended in 1 ml
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LB medium. Dilutions of the cell suspension were streaked on LB agar plates con-
taining the appropiate antibiotics. Plates were incubated overnight at 37 ℃.
2.6.7 Transpsoson Mutagenesis and Arbitrary PCR
Transposon mutagenesis was performed with the mariner transposon as previously
described in Kulasekara et al. (2005). Cells of E. coli S17λpir (de Lorenzo & Timmis,
1994) carrying the mariner transposon on the plasmid pTB20 and of P. aeruginosa
PAO1 were harvested from agar plates. OD578 of 40 for the E. coli strain and OD578
of 20 for PAO1 were adjusted in LB medium. 25 µl of each strain was mixed and
dropped on an agar plate dried for 30 min and finally incubated for 6 h at 37 ℃.
During this time the mobilizable plasmid containing the transposon is transferred.
After incubation the cells were scraped and resuspended in 1 ml LB. For selection,
the cells were incubated with a ten fold excess of the LPS specific phage JG004
for 30 min at 37 ℃. The cells were plated on LB medium containing 200 µg/ml
gentamicin and 10 µg/ml chloramphenicol for the inhibition of the E. coli S17λpir
strain.
Table 7: List of primer for arbitrary PCR. Primers are described in 5’ - 3’ orientation.
Primer Sequence PCR round
P1 (oJG016) TCTACGTGCAAGCAGATTACGGTGAC 1
P2 (oJG007) GGCCACGCGTCGACTAGTACNNNNNNNNNNGATAT 1
P3 (oJG008) GGCCACGCGTCGACTAGTACNNNNNNNNNNACGCC 1
P4 (oJG005) GATATCGACCCAAGTACCGCCACCTA 2
P5 (oJG009) GGCCACGCGTCGACTAGTAC 2
The insertion of the transposon was identified by arbitrary PCR and sequenc-
ing as described previously (O’Toole & Kolter, 1998). Arbitrary PCR consists
of two PCR rounds. In the first round one primer (P1) binds specifically to the
transposon whereas two other primer (P2 and P3) binding randomly in the genome
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of P. aeruginosa. In the second round the PCR products of the first round were
amplified again by using a primer (P4) which also binds to the transposon and
primer P5 which binds specifically to the sequences of primer P2 and P3. The se-
quences of the primers are summerized in Table 7. The PCR mixture is for both
PCR rounds alike and the same as described in 2.6.1. For the second PCR 1 µl of the
first PCR product was used after purification using the QIAquick PCR Purification
Kit according to manufacturer‘s instructions.
The following PCR conditions were used:
1. PCR 95 ℃ 5 min
94 ℃ 30 sec
30 ℃ 30 sec
72 ℃ 1 min
Repeating step two to four 6 times
94 ℃ 30 sec
45 ℃ 30 sec
72 ℃ 1 min
72 ℃ 5 min
Repeating step five to seven 30 times
2. PCR 94 ℃ 30 sec
45 ℃ 30 sec
72 ℃ 1 sec
72 ℃ 5 min
Repeating step one to three 30 times
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2.6.8 Cosmid Library Screen
Cosmid library screening was performed to complement the mutation of the LPS
mutants and to identify the mutated gene. The cosmid library is described elsewhere
(Schobert & Görisch, 1999). After introducing the cosmid via mating (2.6.6) in the
P. aeruginosa LPS mutant TM5 the cells were selected with a tenfold excess of the
phage SZ01 which binds specifically to the truncated LPS. Bacteria were incubated
for 30 min at 37℃ with the phage SZ01 and then plated on LB agar plates containing
tetracycline. Single clones were investigated for wild type LPS and the cosmid was
isolated. Therefore 10 ml overnight culture of the clones were treated as described in
2.6.5. Before investigation of the cosmid it was first introduced in E. coli DH10B via
transformation (2.6.4) and then again isolated to gain DNA of higher purity (2.6.5).
To determine the size of the cosmid insert restriction enzymes cutting upstream
and downstream of the insert were used as described in 2.6.3 and analysed via
gelelectrophoresis (2.6.2). Finally the genomic region covered by the insert of the
cosmid was identified by sequencing (2.8.1) using primers binding to the multiple
cloning site of the cosmid.
2.6.9 Phage DNA Preparation
A phage stock (2.5.10) was incubated with 25 U benzonase (Sigma) at 37 ℃ for
30 min to remove all remaining nucleic acids of P. aeruginosa cells which were used
for the propagation of the phages.
Phages were precipitated using 10 % polyethylenglycol. Therefore, ice cold buffer
1 was added to the phage stock and incubated 1 h on ice. This was followed by
10 min centrifugation at 4 ℃ and 13,000 rpm (Heraeus Biofuge fresco). The super-
natant was discarded and the pellet was resuspended in buffer 2. To break open the
envelope of the phages and release the phage DNA, SDS with a final concentration
of 0.5 % and proteinase K (50 µg/ml) was added and incubated for 1 h at 56 ℃.
After chilling the sample to RT phenol chloroform extraction was performed to re-
move the proteins from the phage envelope. The extraction was done at least 3
times until there was no interphase visible anymore.
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Precipitation of DNA occured with 2.5 volumes of ice cold 100 % ethanol at -20 ℃.
After centrifugation for 15 min at 4 ℃ and 13,000 rpm (Heraeus Biofuge fresco) the
DNA was washed twice with 70 % ethanol, solubilized in 50 µl dH2O and stored at
-20 ℃.
To identify a linear phage chromosome the isolated DNA was treated with the
exonuclease Bal31 according to manufacturer‘s instructions. This enzyme degrades
only double-stranded linear DNA from both ends simultaneously. The digestion was
analyzed by agarose gelelectrophorese (2.6.2).
Buffer 1: 30 % Polyethylenglycl (PEG 6000)
3 mM NaCl
in dH2O
Buffer 2: 10 mM Tris HCl, pH 7.8
5 mM EDTA
in dH2O
SDS stocksolution: 20 % (w/v) SDS in dH2O
Proteinase K stocksolution: 20 mg/ml in dH2O
2.7 Construction of P. aeruginosa Knockout Mutants
To obtain unmarked gene deletion mutants, the well-established strategies based
on sacB counter selection and FLP recombinase excision (Hoang et al., 1998) was
used. To construct the suicide vectors pJG002 and pJG003 the BamHI digested
gentamicin resistance cassette of pPS858 was cloned between two PCR fragments
in the multiple cloning site of pEX18Ap. The two PCR fragments contained DNA
homologs to the upstream and downstream regions of the knockout gene. The
primers used to amplify these regions, the size of the PCR product and the restriction
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sites are depicted in Table 8 and Table 9.
Table 8: List of primer for mexR gene deletion. Primers are described in 5’ - 3’ orientation.
The restriction site is underlined. Primer oJG031 and oJG032 are forward and reverse
primer for upstream region. oJG033 and oJG034 are forward and reverse primer for
downstream region.
Primer Sequence Restriction site Size
oJG031 CGAGCTCTGAGGATGATGCCGTTCAC SacI 516 bp
oJG032 CGCGGATCCTGGTTTGGCCGAGTAAA BamHI
oJG033 CGCGGATCCTTACTGGCGAATGCCTT BamHI 450 bp
oJG034 CCCAAGCTTCTGTACGGCCGCTTCAA HindIII
Table 9: List of primer for PA5001 gene deletion. Primers are described in 5’ - 3’ orien-
tation. The restriction site is underlined. Primer oJG099 and oJG100 are forward and
reverse primer for upstream region. oJG101 and oJG102 are forward and reverse primer
for downstream region.
Primer Sequence Restriction site Size
oJG099 CGAGCTCCCGCAGGCATTGTTGCACTA SacI 402 bp
oJG0100 CGCGGATCCCAGCATGGCGGCTCGAA BamHI
oJG101 CGCGGATCCAGTAGCAGCCGAAAAGA BamHI 516 bp
oJG102 CCCAAGCTTCATGTGTGCCACCTGTT HindIII
The knockout constructs were first introduced into E. coli DH10B by transformation
(2.6.4). Plasmids of carbenicillin and gentamicin resistant cells were isolated (2.6.5)
and controlled by restriction analysis (2.6.3).
Finally, the plasmids were transferred to P. aeruginosa via a diparental mating
(2.6.6). For selection, the cells were plated first on LB agar plates containing
gentamicin. The pEX18Ap plasmid is not able to replicate in P. aeruginosa. Cells
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can only grow when the gentamicin resistance casette was integrated into the genome.
This integration occurs upstream and downstream of the knockout gene due to the
homologue regions. A single cross over leads to integration of the plasmid but not to
a deletion of the gene itself. Therefore a double cross over is required. Clones were
selected on LB agar plates containing 5 % sucrose and gentamicin. The plasmid
pEX18Ap contains a sacB gene which encodes a levansucrase. A toxic product is
produced by this protein in the presence of sucrose. Due to this selection only car-
benicillin sensitive clones with integrated gentamicin casette and removed plasmid
can grow. The clones were stored at -80 ℃ (2.5.5).
2.7.1 Verification of Pseudomonas aeruginosa Knockout via PCR
Removal of Gentamicin Resistance Cassette
After a successful knockout the gentamicin resistance cassette was removed from the
genome. This resistance cassette from pPS858 is flanked by FRT (Flp recombinase
target site) recognition sequences. By using a Flp-recombinase the resistance cas-
sette could be removed from the genome (Hoang et al., 1998). The Flp-recombinase
which is encoded on the plasmid pFLP2 binds to the FRT recognition sequence
and removes the interjacent parts from the genome. The plasmid pFLP2 was first
introduced into E. coli ST18 by transformation (2.6.4) and then transferred into P.
aeruginosa via a diparental mating (2.6.6). For selection, the cells were plated first
on carbenicillin. During the expression of the plasmid in P. aeruginosa the Flp-
recombinase catalyzes the excision of the resistance cassette and leaves a single FRT
sequence of approximately 150 bp. After excision the cells were plated on LB with
5 % (w/v) sucrose to remove the plasmid pFLP2. This plasmid contains the sacB
gene, encoding a protein which produces a toxic product when sucrose is present.
Therefore only cells which lost the plasmid can grow on sucrose. Finally the clones
were tested on carbenicillin and gentamicin to test if the gentamicin resistance cas-
sette was removed and the plasmid pFLP2 is eliminated.
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PCR Verification
To verifiy the knockout mutant a PCR was performed (2.6.1). The primer which
bind upstream and downstream of the homologue sequences were used and are listed
in Table 8 and Table 9. During PCR the DNA upstream and downstream of the
excised gene was amplified. As a control the same PCR was performed with the wild
type PAO1. The PCR products were documented with agarose gelelectrophorese
(2.6.2) and compared with a DNA size standard.
2.8 DNA Sequencing
2.8.1 Sequencing of Single Genes
DNA sequences were obtained with an Abi PrismTM 310 Genetic Analyzer in our
institute. The required preparatory PCR with fluorescence-labeled ddNTPs and
purification of the PCR product were carried out as described by the manufacturer.
The primer used to amplifiy single genes are listed in Table 10.
Table 10: List of primer used for amplification of single genes. Primers are described in
5’ - 3’ orientation.
Primer Sequence Amplified gene Size
oJG019 AAGACTTCGGCATCAAGATGGACCTC mexR 735 bp
oJG020 TTTTAGCTCGATGGCCGGTTATCCAC
oJG021 AAATGACCAGCGTCAACCCTAACGAG nalC 836 bp
oJG022 GTCACCGAGATCCA CCTCACCGAACT
oJG023 TCGAAATACTTCGAGTCCGCCCGAGC nalD 772 bp
oJG024 CCGGCTCGACAGCACCCAGGTACT
oJG095 TGCGTCGGCACGAGTTGTTC PA5001 1177 bp
oJG096 TGCGATCTTCATCGGTCCTA
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2.8.2 Sequencing of Phage Genomes
Whole genome sequencing of the phages JG004 and JG024 was done at the McGill
Universtiy and Génome Québec Innovation Centre (Montréal, QC, Canada) using
454 Technology. A 71 fold coverage of the genomes was achieved.
2.8.3 Annotation of Phage Genomes
The annotation of the unknown phage genes were done by using the software
GeneMark.HMM (Besemer & Borodovsky, 1999) (http://exon.biology.gatech.edu/).
The Heuristic approach of GeneMark was used to identify genes in small genomes
under 100 kb. The identified genes were compared with the NCBI ORF finder
(Wheeler et al., 2003) (http://www.ncbi.nlm. nih.gov/gorf/gorf.html). Nucleotide
sequences were scanned for homologues using the Basic Alignment Search Tool
(blastx) (Altschul et al., 1997) (http://blast.ncbi. nlm.nih.gov/Blast.cgi). To search
for tRNA genes in the phage sequences the internet tool tRNAscan-SE 1.21 (Lowe
& Eddy, 1997) (http://lowelab.ucsc.edu/tRNA scan-SE/) was used.
Sequence comparison and distance phylograms with the PB1-like phages was con-
ducted using ClustalW2 online analysis tool (Larkin et al., 2007) (http://www.ebi.ac.
uk/Tools/clustalw2/index.html). Investigation of the codon usage was performed
using a software tool based on JCat (Grote et al., 2005).
2.9 Preparation and Visualization of LPS
To investigate the LPS from P. aeruginosa the LPS was isolated and analyzed by
a two-buffer tricine-based SDS-PAGE system. The isolation of the LPS was per-
formed as described previous by Coyne et al. (1994). First a bacterial lawn on LB
agar plates was prepared and incubated over night at 37 ℃. The cells were har-
vested and resuspended in 1 ml PBS buffer to an OD578 of 10. The cell suspension
was autoclaved and mixed for at least 1 min. After centrifugation for 2 min and
13,000 rpm (Eppendorf MiniSpin) the supernatant was mixed with a fourfold vol-
ume of 95 % ethanol. This was followed by a precipitation at -20 ℃ over night and
a centrifugation for 10 min at 13,000 rpm (Eppendorf MiniSpin). The pellet was
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resuspended in 200 µl of PBS buffer. Benzonase was added with a concentration
of 3 U and incubated for 2 h at 37 ℃. In the end Proteinase K (100 µg/ml) was
added and the sample was incubated at 56 ℃ over night to remove all the remain-
ing proteins. The isolated LPS was stored at -20 ℃ until analysis. The two-buffer
tricine-based SDS-PAGE is based on Schägger & von Jagow (1987) and consists of a
4 % stacking gel and a 16.5 % separating gel. Before analysis by SDS-PAGE, 3 µl of
the LPS sample was combined with an equal volume of 2 x sample buffer and heated
to 95 ℃ for 5 min. For seperation of the LPS a cathode buffer with a pH of 8.25
and an anode buffer with a pH of 8.9 was used. First an amperage of 15 mA was
applied until the sample reached the seperating gel then the amperage was elevated
to 30 mA. Before silver staining with 0.1 % silver nitrate the gels were incubated
in acetic acid for 30 min. After 5 min washing in dH20 the gels were developed in
2.5 % sodium carbonate solution for 2-5 min. To stop the development, the gels
were transferred into a stop solution.
Acrylamide stock solution Rotiphorese Gel 30 (37.5:1) (Roth)
Anode buffer 200 mM Tris
in dH2O, pH 8.9
Cathode buffer 100 mM Tris
100 mM Tricine
0.1 % (w/v) SDS
in dH2O, pH 8.25
Gel buffer 3.0 M Tris
0.3 % (w/v) SDS
in dH2O, pH 8.45
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SDS sample buffer 0.2 % Bromphenolblue
10 % β Mercaptoethanol
40 % Glycerol
3.2 % (w/v) )SDS
100 mM Tris HCl
in dH2O, pH 6.8
4 % stacking gel 670 µl Acrylamide stock solution
630 µl Gel buffer
1.2 ml dH2O
2.5 µl Tetramethylen diamine (TEMED)
17.5 µl APS (10 % (w/v) in dH2O)
16.5 % seperating gel 2.75 ml Acrylamide stock solution
1 ml Gel buffer
250 µl Glycerol
5 µl Tetramethylen diamine (TEMED)
50 µl APS (10 % (w/v) in dH2O)
Fixing solution 10 % (v/v) Acetic acid
Staining solution 0.1 % (w/v) Silver nitrate
in dH2O
Developer 2.5 % (w/v) Sodium carbonate
0.1 % (v/v) Formaldehyde
0.001% (w/v) Sodiumthiosulfate
in dH2O
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Stop bath 2 % (w/v) Glycine
0.5 % (w/v) EDTA
in dH2O
2.10 Preparation and Visualization of Outer Membrane
Proteins
To investigate outer membrane proteins of P. aeruginosa the proteins were isolated
as previously described in Carlsohn et al. (2006). Twenty ml of a P. aeruignosa
overnight culture were pelleted and washed twice with 20 mM Tris-HCl, pH 7.5.
Three units of benzonase (Sigma) and 0.1 mg/ml protease inhibitor were added.
The cells were broken by repeated ultrasonication (5 x 2 min). Incubation for 30
min at room temperature to digest the nucleic acid was followed by 10 min cen-
trifugation at 4000 rpm (Heraeus Megafuge) to remove cell debris. The supernatant
was centrifuged at 50.000 x g for 40 min. The pellet was dissolved in 5 ml 20 mM
Tris-HCl, pH 7.5 and 2 % (w/v) sodium lauryl sulfate. Incubation for 30 min at
room temperature led to precipitation of the proteins. A final centrifugation for
30 min at 50.000 x g precipitates the proteins which can be dissolved in 20 µl XT
sample buffer. The protein concentration was determined using the 2D-Quant Kit
(Amersham Biosciences) according to manufacturer‘s instructions. Fifty µg protein
were loaded on a 15 % SDS gel for electrophoretic seperation of the outer membrane
proteins. For visualization of the proteins the gels were stained with ruthenium(II)-
tris-(bathophenanthroline disulfonate) as described in Rabilloud et al. (2001). Pro-
tein identification was performed using mass spectrometry as described in Schreiber
et al. (2006).
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XT sample buffer 62.5 mM Tris-HCl
25 % Glycerol
2 % SDS
0.01 % Brominephenolblue
5 % Mercatoethanol
in dH2O
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3.1 Characterization of Two P. aeruginosa Broad Host Range
Phages
During this work 58 P. aeruginosa specific phages were isolated from the sewage
treatment plant Steinhof in Braunschweig. The aim was to isolate and characterize
lytic broad host range phages which infect different P. aeruginosa strains. Two
phages, JG004 and JG024, were selected for detailed characterization.
3.1.1 Host Range of Phage JG004 and JG024
The term "host range" of a phage is defined by which bacterial genera, species and
strain a phage can lyse. P. aeruginosa shows clonal differences since it depicts a core
genome plus variable accessory segments (Wiehlmann et al., 2007). These variable
segments are mobile islands and elements which can be exchanged between strains
and therefore cause a striking diversity among the P. aeruginosa population (Pirnay
et al., 2009). These diversity can also aﬄict the receptors of the phages like the LPS.
There are 20 major serogroups of P. aeruginosa known reflecting only the diversity
of the O-antigen (King et al., 2009). To investigate the host range of the phages
we used different isolates of CF patients, urinary tract infections as well as a set of
environmental strains to cover as much as possible different P. aeruginosa clones.
Table 11 shows the used clinical P. aeruginosa isolates and wild types as well as the
results of the host range for phage JG004 and JG024. JG004 is able to infect nearly
48 % of the tested strains, whereas JG024 is able to infect even 85 % of all tested
strains. The phage JG004 showed a clear lysis in 50 % of the infection events. For
JG024 a clear lysis was observed for 83 % (Tab. 11). Also, both phages were able
to infect a mucA mutant strain. This mutant produces large amounts of exopoly-
saccharides which results in a mucoid phenotype (Martin et al., 1993) suggesting
that mucoidy does not protect clinical isolates from phage infection.
Moreover, in cooperation with Marlon Kazmierczak the host range of the isolated
phages described in this work was determined with a collection of 100 environmental
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Table 11: Host range of phage JG004 and JG024 with clinical isolates. Lysis of bacteria
was determined as described in 2.5.13 and catergorized as clear (+), turbid (0) or no
lysis (-). Clear lysis indicates a complete lysis, whereas a turbid plaque indicates partiell
lysis.
P. aeruginosa strain JG004 JG024
PAO1 + +
PA14 - +
BT2 - +
BT72 - 0
BT73 - +
RN3 - +
RN43 - +
RN45 0 +
NN84 - -
PACF15 - +
PACF21 + +
PAKL1 - -
PAKL4 0 0
PACF60 + +
PACF61 + +
PACF62 - +
PACF 63 0 +
∆mucA + +
MH 18 0 -
MH 19 + +
MH 26 0 0
MH 29 - +
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P. aeruginosa strains. The strains were isolated from different rivers (Oker, Aller,
Weser) in Lower Saxony, Germany. JG004 was able to infect 49 % of the tested
strains, whereas JG024 was able to infect 50 % of the strains (Fig. 4). Interestingly,
JG004 showed a clear lysis for 90 % of the tested strains whereas JG024 showed a
clear lysis only in 45 % of the cases.
These still limited number of infection experiments indicate that JG024 is able to
infect the clinical isolates more effective than JG004 whereas JG004 infect environ-
mental isolates more efficiently. However, the presented results indicate that both
phages, JG004 and JG024, have a broad host range activity.
Figure 4: Host range of JG004 and JG024. One hundred environmental Pseudomonas
aeruginosa strains were tested. JG004 was able to infect 49 strains, JG024 infected 50
strains. The dark grey area indicated the clear lysis in percent. Light grey indicated a
partial lysis in percent.
In comparison to the described results, Knezevic et al. (2009) isolated 19 P. aeru-
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ginosa phages with broad host spectrum and identified phages which infected be-
tween 15-76 % of 33 tested P. aeruginosa strains. The used P. aeruginosa strains of
this study were isolated from human and animal pathological material (22 strains)
as well as from the environment (10 strains). Moreover, five strains belonging to the
familiy Enterobacteriaceae were also used for the host range experiments but none
of the phages was able to lyse these species.
3.1.2 Receptor of Phage JG004 and JG024
Diverse structures on the surface of Gram negative bacteria, as the LPS, outer
membrane proteins, flagella and pili can serve as receptors for phages (Kutter &
Sulakvelidze, 2005). To identify the receptor of the phages JG004 and JG024, dif-
ferent P. aeruginosa mutant strains which lack flagella (∆fliM ), pili (∆pilA) or a
complete LPS (∆algC ) were used.
Figure 5: Identification of potential receptors of phage JG004 and phage JG024. Phages
JG004 and JG024 were directly spotted onto bacterial lawns containing the indicated
Pseudomonas aeruginosa wild type and mutant strains. P. aeruginosa mutant strains
lack flagella (∆fliM ), pili (∆pilA) or a complete LPS (∆algC ). Clear zone indicates
infection of the strain.
50
3 Results and Discussion
The gene algC is needed for a complete core in P. aeruginosa LPS (Coyne et al.,
1994). Phages were directly spotted onto an bacterial lawn as described in 2.5.13.
After incubation, lysis was determined. Both phages were able to lyse the P. aeru-
ginosa flagella and pili mutant but not the LPS mutant (Fig. 5). Since both phages
are not able to infect this mutant it is likely that the phages specifically bind to the
LPS core.
3.1.3 Family Characteristics - Morphology and Nucleic Acid
As described in 1.1 there is no numerical taxonomy for viruses and classification is
based in the morphology and the nature of the nucleic acid.
Figure 6: Restriction pattern of dsDNA of phage JG004 and JG024. Shown are images
of 1 % agarose gels stained with ethidiumbromide. DNA of JG004 was digested with
HindIII and DNA of JG024 with SacII. M: Molecular weight marker.
The vast majority of phages contain a single DNA molecule (Abedon, 2009). There-
fore, the DNA of the phages was isolated as described in 2.6.9. After the isolation,
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the DNA was digested with restriction endonucleases (2.6.3) which cleave exclusively
dsDNA. The DNA was successfully digested indicating that both phages contain ds-
DNA (Fig. 6). The DNA of phage JG004 was digested by HindIII whereas the
DNA of JG024 was digested by SacII. HindIII couldn’t cleave the DNA of JG024
suggesting that there are no HindIII recognition sites present in the respective phage
genome or the phage DNA contains modified bases preventing digestion by HindIII.
Figure 7: Known morphotypes of bacteriophages (Ackermann, 2007)
Moreover, different restriction patterns indicate different phages. In this case it is
obvious that the DNAs of the phages are different since it was not possible to cleave
the DNA of JG024 with HindIII in comparison with JG004 (Fig. 6). Also, the
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DNA of JG024 could not be cleaved by the restriction endonuclease SspI whereas
the DNA of JG004 was cleaved by SspI (data not shown) which underlines the dif-
ference between these phages.
Fig. 7 shows the known morphotypes of phages. Each phage family has a characteris-
tic morphology, therefore, phages can be easily assigned to a family by comparison.
To investigate the morphology of the phages JG004 and JG024 electron microscop-
ical pictures were taken (Fig. 8).
Figure 8: Electron microscopical picture of phage JG004 (A) and JG024 (B). Pictures
were taken by M. Rohde at the HZI to allow family affiliation which is based on the
morphology of the phages. Both phages have a contractile tail, JG004 with a length of
150 nm and JG024 with a length of 130 nm. The head of JG004 has a length and a
width of 60 nm whereas the head of JG024 has a length of 80 nm and a width of 75 nm.
Therefore both phages belong to the family Myoviridae
Both electron microscopical pictures show tailed phages. The tail of the phages
are contractile and consist of a neck, a contractile sheath and a central tube. It
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can be concluded that these phages belong to the family Myoviridae due to their
morphology and their dsDNA. The family Myoviridae belongs with two other tailed
phage families, Siphoviridae and Podoviridae, to the order Caudovirales. Tailed
phages are probably extremely ancient because they infect both Eubacteria and
Archaea. Moreover, they are the most numerous and ubiquitous of all viruses. 25 %
of tailed phages belong to the family Myoviridae (Clokie & Kropinski, 2009).
3.1.4 Growth Characteristics
A number of parameters like the latent phase and the burst size are known to
describe the infection cycle of a phage.
Figure 9: One step growth curve of phage JG004 (solid line) and phage JG024 (dashed
line). Cells from exponential growth phase were infected with phages in a 3:1 ratio and
incubated at 37 ℃ as described in 2.5.15. Samples to determine the phage titer were
taken at indicated time points. Arrows indicate the latent phase and the burst size of
the phages.
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To determine these parameters one step growth curves were performed (2.5.15).
Thereby, the bacteria and viruses in this experiment were mixed in a ratio that only
one phage is likely to adsorb to a bacterium. Moreover, it is best to infect bacteria
in a exponential growth phase to have metabolic active cells (Kutter & Sulakvelidze,
2005). Fig. 9 shows the single step growth curves of the phages JG004 and JG024 by
comparison. Phage infection starts with the attachment to the host bacterium and
the injection of the nucleic acid into the host. The number of free phages decreases
during this phase which can be observed in the single step growth curve. The time
from infection until the first new, infective phages are released from the cell is called
latent phase as indicated in Fig. 9. The latent phase for phage JG004 is shorter
than for phage JG024. The latent phases could be estimated as 15 min for JG004
and 25 min for JG024 (Tab. 12).
After the latent phase, the number of phages in the culture increases suddenly which
represents the number of released phage progeny. The burst size which describes the
mean number of phages liberated per bacterial cell was calculated as described in
Material and Methods (2.5.15). Wang (2006) pointed out that the duration of the
latent phase correlates with the burst size. The longer the latent phage the bigger
the burst size of the phage. Since phage JG024 has a longer latent phase this phage
is able to produce approximately 120 phages per infected cell. On the other hand,
phage JG004 has a short latent phase of only 15 min and the burst size is therefore
smaller with only 27 phages per infected bacterium (Tab. 12).
Table 12: Growth characteristics of phage JG004 and JG024
Phage Duration of infection Burst size
JG004 15 27 phages per cell
JG024 25 120 phages per cell
Moreover, the phage JG004 is able to carry out two infection cycles in the same
time JG024 is able to carry out only one infection cylce (Fig. 9). The growth curve
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of JG004 describes a first peak after a first burst at around 25 min. Afterwards,
the number of phages decreases again due to binding of the phages to bacteria and
finally a second burst increases the total number of phages.
3.1.5 Sequence Analysis of JG004 and JG024
Phage genomes were sequenced using the 454 Technology at the McGill Universtiy
and Génome Québec Innovation Centre (Montréal, QC, Canada).
General properties like the genome size, the GC content and the number of possible
ORFs are summarized in Table 13. The GC content and the annotation of genes
were done by using the software GeneMark (Besemer & Borodovsky, 1999). The
possibility of genes coding for tRNAs was investigated using the tool tRNAscan-SE
1.21 (Lowe & Eddy, 1997).
Table 13: General properties of the JG004 and JG024 genome.
Phage Genome size GC content (%) predicted ORFs tRNA genes
JG004 93,010 bp 49.26 160 12
JG024 66,275 bp 55.62 94 no
The genome size of phage JG024 is 66,275 bp, with 94 putative ORFs and has a
GC content of 55.62 %. No genes encoding for tRNAs were found. The genome of
phage JG004 is significantly larger with 93,010 bp, 160 putative ORFs and a GC
content of 49.26 %. Moreover, the genome of phage JG004 contains 12 tRNA genes
(Tab. 14), the cloverleaf structure is shown in Fig. 29 (Appendix).
Normally, phages utilize the host’s protein synthesis machinery to synthesize their
own proteins and enzymes, but some phages encode their own tRNAs. tRNAs were
most commonly found in the members of the Myoviridae with large genomes (Clokie
& Kropinski, 2009). Kropinski & Sibbald (1999) pointet out that tRNA genes in
phages are almost always clustered and that they may facilitate a more rapid overall
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Table 14: tRNAs of phage JG004.
tRNA Begin End Amino Acid Anti Codon Length
1 58738 58666 Glu TTC 72
2 58821 58748 Phe GAA 73
3 58903 58831 Gly TCC 72
4 58987 58913 Pro TGG 74
5 59126 59054 Asn GTT 72
6 59212 59140 Cys GCA 72
7 59700 59625 Asp GTC 75
8 59785 59713 Ile GAT 72
9 60080 59999 Leu TAG 81
10 60431 60358 Lys TTT 73
11 60513 60442 Arg TCT 71
12 60892 60822 Gln TTG 70
translation rate, especially the translation rate for rare codons. Interestingly, the
tRNA genes in JG004 are also clustered and since this phage has a really short
infection cycle of less than 15 min the phage tRNAs could be helpful to achieve
a higher overall translation rate. They may function in the translation of certain
highly produced proteins since the GC content of phage JG004 with 49.26 % differs
from the GC content of the host P. aeruginosa with 68 %. Comparison of the codon
usage with the host showed that phage JG004 shares the same dominant codons for
the following amino acids: isoleucine (AUC), tyrosine (UAC), cysteine (UGC), histi-
dine (CAC), tryptophan (UGG), asparagine (AAC), lysine (AAG), leucine (CUG),
aspartic acid (GAC), phenylalanine (UUC) and glutamic acid (GAG) (Tab. 18, Ap-
pendix). Interestingly, phage JG004 features own tRNAs for the dominant codons
of phenylalanine (UUC), aspartic acid (GAC), asparagine (AAC), isoleucine (AUC)
and cysteine (UGC) probably to achieve a higher overall translation rates. More-
over, the other tRNAs ensure a translational efficiancy for codons which are not so
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freuquently or rarely used in P. aeruginosa as in the phage JG004 (glutamic acid
(GAA), glycin (GGA), proline (CCA), leucine (CUA), lysine (AAA), arginin (AGA)
and glutamine (CAA)) (Tab. 18, Appendix).
Interestingly, the GC content of phage JG024 also differs from its host (55.62 % to
68%). Comparison of the codon usage of JG024 with its host P. aeruginosa showed
that the phage shares the same dominant codons for each amino acid exept for
valin, serin and glutamat and therefore ensuring translational efficiancy (Tab. 18,
Appendix).
The annotated genes and their predicted function are listed in Table 19 and Table 20
of the Appendix. The schematic representation of the genomes, with their predicted
ORFs, some functional assignments and overall genetic organization are depicted in
Fig. 10 and 12.
Features of JG004 Genome
Eighty three (52 %) of the 160 predicted ORFs show no similarities to other genomes
in databases. The genome of phage JG004 shows 11.3 % intergenic space. This is
comparable with the host P. aeruginosa PAO1 which shows 10.6 % non coding re-
gions (Stover et al., 2000). Some bigger non coding regions of the JG004 genome
were observed in the area of the coding regions for the tRNAs and between ORF
141 to 145.
Since ORF 85 has similarities to RNA polymerases, the phage JG004 is probably not
dependant on the host transcriptional machinery. Moreover, genes encoding for the
DNA replication machinery were found, suggesting that the DNA replication is also
independent from the host. We found ORFs with similarities to a DNA polymerase
(ORF 40), a DNA helicase/primase (ORF 41), a thymidylate synthetase (ORF 21),
a ribonucleotide reductase (ORF 18) and for a exodeoxyribunuclease (ORF 34). A
terminase like gene (ORF 92) could also be detected. Phage terminases are the
DNA packaging enzymes and among the most conserved proteins found in phages.
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Figure 10: Schematic representation of the JG004 genome with its assumed ORFs and some functional assingments. The arrowheads
point in the direction of transcription.
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Terminases have ATPase activity that powers the DNA translocation into the virion.
Some terminases also contain endonuclease activity to cut the DNA into genome
length (Rao & Feiss, 2008).
Two putative endonucleases were also detected (ORF 81, 106). These endonucleases
could be involved in the DNA packaging process or in host nucleic acid damaging.
Moreover, two putative methyltransferases were found. Methyltransferases are im-
portant for the methylation of DNA to protect the DNA against own endonucleases
or endonucleases of the host which serve as a protection against foreign DNA and
infection of phages.
Only five ORFs were found with similarities to phage particle proteins. Two of them
are putative tail fiber proteins (ORF 66 and 67) and two of them are putative base-
plate components (ORF 69 and 71). ORF 82 has similarities to a putative structural
protein of the Erwinia phage phiEa21-4. None of these proteins have similarities
to head structural proteins, suggesting that the phage is not related to any other
sequenced phage since it contains unique structural proteins.
A putative tape measure protein was also detected (ORF 75) close to the putative
structural proteins. It was shown for phage T4 that the so called tape measure
protein regulates the length of the phage tail (Abuladze et al., 1994). Moreover, it
was described for Mycobacteria specific phages that the tape measure protein facili-
tates phage entry into stationary phase cells with thickened peptidoglycan layer due
to a peptidoglycan hydrolase motif (MT3 motif) associated with the tape measure
protein (Dusthackeer et al., 2008).
Lysis of bacteria by phages with dsDNA is accomplished by two main proteins, an
endolysin which degrades the peptidoglycan and a holin which permeabilize the cy-
toplasmic membrane to facilitate entry of the endolysin into the periplasm (Young
et al., 2000). We found one putative cell wall hydrolase (ORF 113) among the
identified ORFs. This hydrolase has similarities to the cell wall hydrolase SleB of
Methylobacterium populi but not to endolysins of other phages. A conserved protein
domain of the hydrolase 2 superfamily was also detected in this putative cell wall
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hydroalse. However, we couldn’t detect any similarities to a holin which is likely
because holins are very diverse and a are classified into twelve unrelated orthologous
groups (Young et al., 2000).
Relatively small proteins with less than 100 amino acids were found in in the genome
of phage JG004, the smallest one with only 34 amino acids. None of these small
proteins has a predicted function. It was shown before that phage genomes contain
small proteins with unknown function (Miller et al., 2003; Ceyssens et al., 2006;
Weigele et al., 2007). It is speculated that these proteins may have a role as acces-
sory factors that bind to and subtly modify the specificity of host proteins so that
they function appropriately during phage infection (Mann et al., 2005).
Finally, a putative homospermidine synthase was found (ORF 137), although with
sparse identity (34 %, e-value: 0.32). A homospermidine synthase produces ho-
mospermidine and propane-1,3-diamine out of spermidine and putrescine. Homo-
spermidine is a aliphatic polyamine (Tholl et al., 1996). Although it was found
in some bacteria (Hamana & Matsuzaki, 1992), plants (Ober & Hartmann, 2000)
and animals (Matsuzaki et al., 1982), the exact function of homospermidine is still
uncertain.
It is suggested for phages that polyamines like spermidine are important for the
DNA charge balance during DNA packaging (Yu & Schaefer, 2008). The negative
charge of the DNA is shielded by the positive charge of the polyamine and therefore
can be packed very compact.
Moreover, phage JG004 seems to be dependent on spermidine since a P. aeruginosa
speD mutant which has a defect in spermdine synthesis (Heurlier et al., 2006) can
not be lysed by phage JG004 (data not shown).
62
3 Results and Discussion
Features of JG024 Genome
Phage JG024 is highly related to the widespread and conserved PB1-like viruses
(Ceyssens et al., 2009). The general characteristics as well as the similarity to the
phage JG024 are shown in Table 15. The overall nucleotide similarity to the PB1-
like phages varies between 86 % to phage PB1 and 95 % to the phages SN and
14-1 (Tab. 15). A phylogenetic tree showing the relation between these 6 closely
related phages in comparison with the phage JG024 is presented in Fig. 11. The
PB1-like phages reveal a very high sequence similarity and are distantly related to
the Burkholderia phages Bcep1A and Bceo781 (Ceyssens et al., 2009).
Table 15: Comparison of the JG024 genome with the PB1-like phages.
Phage Genome size GC content (%) predicted unique DNA identity
ORFs ORFs to JG024
JG024 66,275 bp 55.62 94 1 100%
PB1 65,764 bp 55.5 93 - 86 %
F8 66,015 bp 55.6 93 1 87 %
SN 66,390 bp 55.6 92 2 95 %
14-1 66,238 bp 55.6 90 - 95 %
LMA2 66,530 bp 55.6 95 2 93 %
LBL3 64,427 bp 55.5 88 2 92 %
The ability to infect a wide range of P. aeruginosa strains as described earlier (3.1.1)
could be one reason for the success and wide distribution of this phage group. More-
over, the phage 14-1 which belongs to this highly conserved phage group is part of
a clinical trial to treat P. aeruginosa infections with phage therapy. The phage was
chosen for this trial due to its prevalence to clinical isolates (Merabishvili et al.,
2009). As described above, we could also show that phage JG024 is able to lyse
several clinical isolates (3.1.1).
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Figure 11: Phylogenetic tree of the phage JG024 and the PB1-like phages. This distance
phylogram was made using the ClustalW online analysis tool. It shows the evolutionary
relationship between JG024 and the other PB-1-like phages.
Since these phages have such a strong similarity a comparative ORF prediction was
possible. The genome of JG024 is compact organized with only 7.1 % intergenic
space. No RNA polymerase was detected suggesting that this phage uses the host
transcriptional machinery, as it was also suggested for the PB1-like family of phages.
A terminase-like gene was found (ORF 4) at the beginning of the genome. The ter-
minase is involved in DNA packaging as discussed for phage JG004. The terminase
of phage JG024 shows 99.6 % identity to the terminase of phage SN.
We detected a putative structural gene cluster in the genome of JG024 which con-
tains genes encoding for putative head structure proteins (ORF 18 and 19) as well
as for tail and baseplate proteins (ORF 22-47). Since this phage is so similar to the
PB1-like phages, it was possible to identify head and tail proteins as well as baseplate
proteins. This was not possible for phage JG004 since this phage shows only simi-
larities to probable tail proteins but not to head proteins. Moreover, ORF 40 was
designated as a lytic tail protein. It was shown for the phages 14-1 and LBL3 that
this protein has a transglycosylase domain with a N-acetyl-D-glucosamine binding
site, which shows a specific degradation of peptidoglycan (Ceyssens et al., 2009).
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Figure 12: Schematic representation of the JG024 genome with its assumed ORFs and some functional assingments. The arrowheads
point in the direction of transcription.
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Moak & Molineux (2004) pointed out that enzymes with muralytic activity were
found in diverse phages and that these enzymes are often associated with large pro-
teins or structural components.
ORF 48 encodes for a putative endolysin with a high similarity to the endolysin
of phage LMA2 (98.6 %) and contains a lysozyme-like superfamily. This protein
accumulates probably in the cytoplasm since it lacks a signal peptide and a cell wall
binding domain as it was shown for the PB1-like phages (Ceyssens et al., 2009).
Therefore, the endolysin is dependant on a holin which penetrates the inner mem-
brane and facilitate access to the peptidoglycan layer (Wang et al., 2000). ORF52
has 100 % identity to ORF 50 of phage F8 and to ORF 51 of phage 14-1. It was
suggested for these phages that this ORF encodes for a probable holin since it is
located near the endolysin, it has a small size (201 aa), and three transmembrane
domains (Ceyssens et al., 2009).
Moreover, a complete DNA replication machinery was detected suggesting that the
DNA replication is host independent as it was described for the PB1-like phages.
This gene cluster contains a DNA ligase (ORF 50), a helicase (ORF 55 and 56), a
DNA polymerase III (ORF 57 and 58), as well as a thymidylate synthase (ORF 61).
A putative primase was also found but is not included in this gene cluster (ORF
76). As shown for the other PB1-like phages (Ceyssens et al., 2009) JG024 uses
the DNA polymerase III, which is the main DNA replication enzyme in bacteria.
The polymerase epsilon subunit which is encoded by the ORF 58 has a proofreading
activity (Kelman & O’Donnell, 1995).
In contrast to phage JG004 no putative endonucleases or methyltransferases which
are involved in DNA modification were detected. As described above (3.1.3) the
DNA of phage JG024 was not cleaved by the restriction enzyme HindIII. Genome
analysis revealed restriction sites for HindIII in the genome of JG024 suggesting
that the DNA is modified. Since no sequence similarities for methyltransferases
could be detected it is possible that there is a new not yet described or annotated
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methyltransferase among the hypothetical proteins.
Several small genes encoding for hypothetical proteins were found. Two major clus-
ters (ORF 1-17 (except ORF 4 which encodes for the terminase) and ORF 80-93)
were identified. As discussed for phage JG004 these proteins may be involved as
accessory factors during phage infection (Mann et al., 2005).
Phage 14-1 (ORF 71) and phage LBL3 (ORF 68) own a hypothetical protein with
a size of 434 aa. This protein is encoded by two ORFs in phage JG024, designated
ORF 72 a (362 aa) and 72 b (60 aa). The two ORFs are seperated by only 116 bp.
ORF 78 is a small predicted gene with a size of 132 bp and encodes for a unique
protein in phage JG024. No similarities were found in databases. False annota-
tion for this ORF was excluded since this ORF was identified by two ORF finder
(GeneMark and ORF Finder) independently.
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3.2 Impact of Antibiotics on Pseudomonas aeruginosa
Lipopolysaccharide
As described in 1.3.2 the opportunistic human pathogen Pseudomonas aeruginosa
exhibits various resistance mechanisms towards antibiotics. Several well-characte-
rized factors as eﬄux pumps or an impermeable outer membrane are known to
contribute to its intrinsic antibiotic tolerance (Strateva & Yordanov, 2009).
Antibiotic use can lead to different mutations in bacteria allowing adaptation to
the antibiotic stress (Schurek et al., 2008). Mutations in the LPS core biosynthesis
cluster leading to a truncation of the LPS was observed in conjuction with antibiotic
use before. Antibiotics like ciprofloxacin (Legakis et al., 1989), gentamicin (Bryan
et al., 1984; Shearer & Legakis, 1985) and also carbenicillin (Godfrey et al., 1984;
Shearer & Legakis, 1985) were used in these studies suggesting that the altered LPS
may impair the uptake of the antimicrobial compound. But still the exact reason
for the alteration of the LPS as well as the exact mutation was not understood.
Since we isolated LPS specific phages we wanted to use these phages in a phage based
in vitro system to investigate LPS mutations induced by antibiotic stress. These
phages can serve as screening tools in random genomic mutagenesis experiments to
identify mutations in the LPS or to monitor the emergence of LPS mutations in
a culture under antibiotic pressure. To screen for P. aeruginosa LPS mutants the
LPS specific phage JG004 was chosen due to its lytic life cycle and the low rate of
spontaneous resistant bacteria occurring during infection (below 0.012 %).
3.2.1 Investigation of Clinical Isolates
Investigation of 23 P. aeruginosa clinical non-CF isolates revealed five mutants with
altered LPS (Fig. 13). Compared to the LPS of a wild type strain as PAO1 the LPS
of these clinical isolates is highly truncated. The thick lower band indicates the lipid
A as well as the inner core polysaccharide of the LPS. Bands above this components
represent the outer core polysaccharide and the O-antigen. Also, infection with the
LPS specific phage JG004 was not possible suggesting that the LPS modification
removed the receptor structures recognized by JG004 (3.1.2).
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Figure 13: Silver stained 16.5 % tricine-SDS gel displaying the truncated LPS of five clinical
isolates. The LPS was isolated as described in 2.9 and 3 µl of each LPS preparation was
loaded to the gel. The arrows designated A and B indicate position of the wild type
and truncated LPS, respectively. The LPS components of P. aeruginosa are indicated.
The LPS is composed of the lipid A, the core polysaccharide and the O-antigen. 1, P.
aeruginosa PAO1; 2, GH06 20934; 3, GH06 21466; 4, GH06 25135; 5, GH06 41910; 6,
GH06 54773-2.
Moreover, all strains showed a high resistance to antibiotics (Tab. 16). Antibiotic
susceptibility test stribes with 16 commonly used antibiotics were used and compared
with the wild type PAO1.
Clearly, the clinical isolates showed increased tolerance to at least 3 antibiotic
classes. Antibiotic classes like β-lactames (ampicillin, piperacillin), flourquinolones
(ceftazidim, ciprofloxacin) as well as tetracyclines are substrates for the clinical rel-
evant eﬄux pump mexABoprM (Schweizer, 2003). Ziha-Zarifi et al. (1999) showed
that antimicrobial treatment of patients infected with P. aeruginosa leads to mu-
tations in the regulator mexR resulting in an overexpressed mexABoprM operon.
Further investigation of the eﬄux pump mexABoprM in these isolates revealed that
at least one of the three repressors of the eﬄux pump, mexR, nalC or nalD, was
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Table 16: Antibiotic susceptibility test. ATB PSE I test strips from BioMérieux were used
as described in 2.5.7. S: sensitive (no growth); I: intermediate (growth at low antibiotic
concentrations); R: resistant (growth at high antibiotic concentrations).
Antibiotic Strain
PAO1 GH06 GH06 GH06 GH06 GH06
20934 21466 25135 41910 54773-2
Ampicillin + Sulbactam R R R R R R
Piperacillin S R I R I R
Piperacillin + Tazobactam S R S R I R
Ceftazidim S R S R I R
Aztreonam I R I R R R
Cefepin S R S R I R
Imipenem S R R S S S
Meropenem S R I I S I
Gentamicin I R S R I I
Tobramicin S I S I S S
Amikacin S I S I S I
Ciprofloxacin S R R R S R
Levofloxacin S R R R I R
Cotrimoxazol R R R R R R
Fosmomycin R R S S R S
Tetracyclin R R R R R R
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mutated which finally results in an overexpression of the eﬄux pump. We amplified
the mexR, nalC and nalD gene by PCR and sequenced the single genes as described
in 2.8.1. Comparison with the wild type identified five point mutations in mexR
of the isolate GH06 21466, one point mutation in mexR of the isolate GH06 20934
as well as ten point mutations in mexR of the isolate GH06 54773-2. The isolates
GH06 25135 and GH06 41910 showed no mutations in mexR but both revealed two
point mutations in nalC and one point mutation in nalD.
These results indicate that the clinical isolates are highly resistant to antibiotics due
to the overexpressed eﬄux pump. However, a possible involvement of the truncated
LPS in antibiotic resistance can not be excluded and was investigated in more detail.
3.2.2 In vitro Phage Based System to Detect LPS Alterations
A transposon mutagenesis using the mariner transposon was performed to verify
that we were able to isolate LPS mutants by using the LPS specific phage JG004
as a screening tool. Moreover, this approach should provide mutants with highly
truncated LPS comparable to the LPS of the clinical isolates. In addition, mutations
of bacterial components essential for phage infection should also be identified. After
the mutagenesis the bacteria were incubated with a tenfold excess of the LPS specific
phage JG004. Bacteria with LPS modifications due to the insertion of the transposon
were not lysed by the phage (Fig. 14).
Twenty three mutants were isolated and the genomic position of the mariner trans-
poson was determined by arbitrary PCR (2.6.7) (Tab. 17). The LPS of the mutants
was isolated and separated via tricine-SDS PAGE (2.9). It is clearly shown that
the LPS profile of 15 mutants are different compared to the wild type PAO1 (Fig.
15). Truncated LPS was observed for the following mutants: mexA (TM2), mexR
(TM5, TM8, and TM11), nalD (TM1, TM6 and TM10), nalC (TM9 and TM14),
wzz2 (TM12), algC (TM15), PA2200 (TM21), rmlB (TM20, TM22) and PA5000
(TM23). The transposon screen revealed genes important for LPS biosynthesis like
the gene algC which is needed for complete LPS core biosynthesis in P. aeruginosa
(Coyne et al., 1994). Or the genes rmlA and rmlB which are involved in the biosyn-
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Table 17: Identified transposon mutants. The mutants were screened with the phage
JG004 and the integration of the transposon was identified by arbitrary PCR.
Transposon mutant Integration of transposon
TM1, TM6, TM10 nalD
TM2 mexA
TM3 speD
TM4 PA0534
TM5, TM8, TM11 mexR
TM7 PA0421
TM9, TM14 nalC
TM12 wzz2
TM13 PA2555
TM15 algC
TM16 PA705
TM17 rmlA
TM18 waaL
TM19 PA5001
TM20, TM22 rmlB
TM21 PA2200
TM23 PA5000
72
3 Results and Discussion
Figure 14: Scheme of in vitro phage based system to screen for LPS variants. The conical
flask represents the mixture of Pseudomonas aeruginosa wild type and LPS variants.
The LPS specific phage JG004 can only bind to the wild type but not to truncated LPS.
JG004 will infect the wild type bacteria, propagate and finally lyse the cells.
thesis of the LPS core sugars (King et al., 2009). However, we identified also 8 out of
23 mutants with LPS similar to the LPS of the wild type PAO1 (TM3 (speD), TM4
(PA0534), TM7 (PA0421), TM13 (PA2555), TM16 (PA0705), TM17 ( rmlA) and
TM18 (waaL) TM19 (PA5001)), suggesting that the transposon integrated in genes
which are important for the phage infection cycle itself and not in a gene relevant
for the receptor. The high amount of strains with truncated LPS (65 %) confirm
that the screen is useful to isolate and identify LPS mutant.
But more interesting was the identification of the mutated regulators mexR, nalC
and nalD among the transposon mutants. Nearly 35 % of the identified mutants
have an integration in one of these regulators. Moreover, the LPS of these mu-
tants appear very similar to the truncated LPS of the clinical isolates. A switch
of of these regulators leads to the overexpression of the eﬄux pump mexABoprM
(Srikumar et al., 2000; Cao et al., 2004; Sobel et al., 2005). Since there are no re-
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Figure 15: Silver stained 16.5 % tricine-SDS gel displaying the LPS profile of the isolated
transposon mutants. The LPS was isolated as described in 2.9 and 3 µl of each LPS
preparation was loaded to the gel. The arrow designated A indicate the position of
the wild type LPS. The LPS components of P. aeruginosa are indicated. The LPS is
composed of the lipid A, the core polysaccharide and the O-antigen. Distinct LPS trun-
cation could be observed for the following P. aeruginosa transposon mutants: 3, TM2
(mexA); 6, TM5 (mexR); 7, TM6 (nalD); 8, TM14 (nalC ); 11, TM15 (algC ); 16, TM21
(PA2200); 17, TM 22 (rmlB); 18, TM23 (PA5000)). No or indistinct LPS modifications
are shown for the the following samples: 1, PAO1; 2, P. aeruginosa mexR deletion mu-
tant; 4, TM3 (speD); 5, TM4 (PA0534); 9, TM7 (PA0421); 10, TM13 (PA2555); 12,
TM16 (PA0705); 13, TM17 (rmlA); 14, TM18 (waaL); 15, TM19 (PA5001).
ports about these regulators involved in LPS biosynthesis we constructed a mexR
deletion mutant (2.7) and investigated the LPS. The LPS of JG09 shows no alter-
ation (Fig. 15, Lane 2) as shown for the transposon mutants mentioned above. This
result indicates that mutation of the gene mexR or the resulting overexpression of
mexABoprM itself does not result in a modified LPS. This suggest that the trun-
cated LPS seems to have its origin in a secondary mutation. Interestingly, we used
two different antibiotics during the transposon screen, gentamicin and chlorampheni-
col (2.6.7). The resulting antibiotic stress is very high for the mutants, suggesting
that secondary mutations leading to a better adaptation under these conditions are
likely. For further experiments the transposon mutants TM5 and TM6 were used
since both contained a highly truncated LPS and a transposon inserted in mexR
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and nalD respectively.
Figure 16: Emerging of Pseudomonas aeruginosa strains with altered LPS in the presence
and absence of carbenicillin. The P. aeruginosa mexR deletion mutant was incubated
in LB (light grey bars) and in LB with 200 µg/ml carbenicillin (dark grey bars) as de-
scribed in 2.5.16. The experiment was carried out for 6 days. Each day, fresh medium
was inoculated and the phage based in vitro system was used to monitor LPS alter-
ations. Each bar indicates the determined percentage of mutants with truncated LPS
per day. The rate of mutants with truncated LPS increases up to 8 % in the presence
of carbenicillin.
3.2.3 Antibiotics Treatment Leads to Lipopolysaccheride Alterations
It is known that antibiotic treated P. aeruginosa overexpresses eﬄux pumps to ex-
clude these substances out of the cell. The overexpression of the eﬄux pumps is due
to mutations in the corresponding regulators (Poole, 2002). However, the involve-
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ment of altered LPS in antibiotic resistance was discussed before (Legakis et al.,
1989; Bryan et al., 1984; Shearer & Legakis, 1985; Godfrey et al., 1984; Diver et al.,
1991; Abraham et al., 2009) but the emergence of these mutants due to antibiotic
treatment wasn’t shown yet.
The phage based in vitro system (2.5.16) was used to monitor the emergence of
mutants with truncated LPS during exposure to antibiotics. The mexR deletion
mutant was used for these experiments because we found LPS mutations in the
clinical isolates as well as in the transposon mutants always connected with an over-
expressed eﬄux pump. Moreover, incubation of this mutant with antibiotics which
are substrates for the eﬄux pump allowed a higher concentration of antibiotics in
the culture.
Figure 17: Silver stained 16.5 % tricine-SDS gel displaying isolated LPS of phage infection
resistant P. aeruginosa clones. The clones were isolated from the phage based in vitro
system to monitor antibiotic induced LPS modifications. All isolated clones display a
modified LPS after antibiotic treatment. The LPS was isolated as described in 2.9 and
3 µl of each LPS preparation was loaded to the gel. The arrows designated A and
B indicate the position of the wild type LPS. The LPS components of P. aeruginosa
are indicated. The LPS is composed of the lipid A, the core polysaccharide and the
O-antigen. The O-antigen structure cannot be observed in this gel due to short silver
staining. 1, P. aeruginosa PAO1; 2-13, Isolated clones from the LPS assay.
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Experiments were performed with the antibiotic carbenicillin which is a substrate
of the mexABoprM eﬄux pump. To test whether the LPS structure changes during
incubation with carbenicillin, we incubated the mexR deletion mutant in LB with
and without the indicated antibiotic over 6 days. Each day we inoculated fresh
medium and screened for LPS mutants with the LPS specific phage JG004. The
resistance frequency of P. aeruginosa ∆mexR incubated with carbenicillin increased
suddenly after 3 days to 4 % and reached a maximum of 8 % after 5 days (Fig. 16).
In the absence of antibiotics the resistance frequency for P. aeruginosa ∆mexR is
below 0.1 %. As a control we isolated 10 clones from this assay and investigated the
LPS biochemically (2.9) (Fig. 17). Clearly, all mutants showed a truncated LPS.
This experiment supports the hypothesis that LPS alterations emerge in response
to antibiotic stress.
3.2.4 Antibiotics Induce Oxidative Stress
Recently, it was shown that the repressor MexR is able to sense oxidative stress
(Chen et al., 2008). The mechanism of this regulator is dependant on two cysteine
residues.
Figure 18: MexR senses oxidative stress. From Chen et al. (2008). MexR contains two
cysteine residues which forms disulfide bonds under oxidizing conditions resulting in a
dissociation of the regulator from the mexR DNA-recognition site.
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These residues form under oxidizing conditions intramonomer disulfid bonds which
lead to the dissociation of the regulator from the promotor DNA (Fig. 18). More-
over, Kohanski et al. (2007) pointed out that bactericidal antibiotics induce oxidative
stress in the bacterial cell by inducing the so-called Fenton reaction. The mechanism
is supposed to be a hyperstimulation of the electron transport chain. Due to this
hyperstimulation single electrons are transferred to oxygen resulting in superoxid
radical production. This radical damages iron sulfur clusters in the cell and allocate
ferrous iron for the Fenton reaction. During the Fenton reaction the very reactive
hydroxyl radical is produced which damages DNA, proteins and lipids in the cell.
Figure 19: Reactive oxygen species assay of Pseudomonas aeruginosa. P. aeruginosa were
grown in LB with (+) and without (-) gentamicin. The cells were flourescence stained
with H2DCFDA (2.5.17). The x-axis describes the flourescence intensitiy of the cells
and the y-axis the cell count.
Since these expermiments were performed in E. coli the same experiment was done
in P. aeruginosa in this work to see if antibiotics induce reactive oxygen species
(ROS) and hence induce oxidative stress in a similar way. During this experiment
the cells were first incubated with carbenicillin, gentamicin or menadione as de-
scribed in 2.5.17 and then incubated with the fluorescence dye H2DCFDA. This dye
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penetrates the bacterial cell and is non-flourescent until it becomes first deacetylated
by intracellular esterases and finally oxidized by radicals. The cleavage of lipophilic
groups by the esterase results in a charged form of the dye which is better retained by
the cells (Rosenkranz et al., 1992). The flourescence was measured by fluorescence
activated cell sorting (FACS). Carbenicillin, gentamicin and as a control the super-
oxid radical producer menadione were used. All three substances induced reactive
oxygen species. Fig. 19 shows the FACS results for cells treated with gentamicin and
cells untreated. Clearly, the flourescence intensity and the corresponding amount of
reactive oxygen species is higher in cells treated with gentamicin. The same results
were obtained with carbencillin and menadione and are not shown.
3.2.5 Mutants with Altered LPS are More Tolerant to Oxidative Stress
I found the emergence of P. aeruginosa mutants with truncated LPS when cultures
were treated with the antibiotic carbenicillin (3.2.3) and showed that antibiotics
induce oxidative stress (3.2.4). The next step was to investigate if the altered
LPS contributes to the tolerance to oxidative stress. To trigger oxidative stress
in P. aeruginosa we used menadione as a superoxide radical producer. Survival
assays were done with different concentrations of menadione as described in 2.5.8.
The transposon mutants TM5 and TM6 as well as the clinical isolate GH06 41910
and the wild type PAO1 were used.
The transposon mutants TM5, TM6 and the clinical isolate showed an increased
survival in the presence of oxidative stress compared with the wild type PAO1
suggesting that the modified LPS of the three strains contributes to the tolerance
(Fig. 20). MIC determinations with menadione and H2O2 also showed that the LPS
alteration has an impact on the resistance of the cell to oxidative stress since strains
with truncated LPS were more tolerant to these substances (Data not shown).
If these mutants have a higher tolerance to oxidative stress than the wild type, the
rate of LPS mutants should increase in an environment with increased oxidative
stress. It was shown that intracellular free ferrous iron increases the production of
the hydroxyl radical by induction of the Fenton reaction (Keyer & Imlay, 1996).
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Figure 20: Survival of different Pseudomonas aeruginosa strains challenged with mena-
dione. P. aeruginosa PAO1 (dash), the P. aeruginosa transposon mutants TM5
(crosses), TM6 (triangles) and the clinical isolate GH06 41910 (squares) after expo-
sure to increasing concentrations of menadione. Incubation time was 4 h at 37 ℃ with
a menadione concentration range of 2.5 mM to 10 mM. After incubation at 37 ℃ the
colony forming unit was determined by serial dilutions as described in 2.5.4 to calculate
the survival rate in percent.
Since ferrous iron can increase the oxidative stress in a culture, LB without ferrous
iron and LB with 1 mM ferrous sulfate to prevent and increase the Fenton reac-
tion and therefore hydroxyl radical production in the cell was used (2.5.16). The
mexR deletion mutant was incubated with and without carbenicillin for 6 days and
inoculated every day into fresh medium as described earlier (3.2.3). In LB medium
without ferrous iron the Fenton reaction is dramatically reduced. As a result no
mutants with a truncated LPS were observed (data not shown). On the contrary,
∆mexR incubated in LB with 1 mM ferrous sulfate and carbenicillin leads to an
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Figure 21: Emerging of Pseudomonas aeruginosa strains with altered LPS in the presence
and absence of carbenicillin and ferrous sulfate. The P. aeruginosa mexR deletion
mutant was incubated in LB (light grey bars), in LB with 200 µg/ml carbenicillin (dark
grey bars) (Fig. 16) and in LB supplemented with 200 µg/ml carbenicillin and 1 mM
ferrous sulfate (black bars) as described in 2.5.16 to induce the Fenton reaction. The
experiment was carried out for 6 days. Each day, fresh medium was inoculated and the
phage based in vitro system was used to monitor LPS alterations (2.5.16). Each bar
indicates the determined percentage of mutants with truncated LPS per day. The rate
of mutants with truncated LPS increases up to 8 % in the presence of carbenicillin and
up to 22 % in the presence of carbenicillin and ferrous sulfate.
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dramatic increase of LPS mutants up to 22 % (Fig. 21). Without ferrous sulfate the
rate of LPS mutants reached a value of only 8 % (Fig. 21). To summarize these re-
sults, we could show that antibiotics induce the emergence of LPS modification in P.
aeruginosa and that the induction of oxidative stress by ferrous sulfate increase the
rate of LPS modifications suggesting that LPS modifications occur due to oxidative
stress induced by antibiotics. High oxidative stress leads to high amounts of LPS
alterations in the population.
3.2.6 PA5001 is Responsible for the LPS Alterations during Antibiotic
Exposure
To identify the mutated gene which leads to the LPS modification we performed a
complementation experiment with a P. aeruginosa cosmid library as described in
2.6.8. To screen for mutants which gained wild type LPS due to complementation,
a phage was isolated which is specific to the truncated LPS of the mutants.
Figure 22: Restriction pattern of isolated cosmids from eleven complemented clones of
the Pseudomonas aeruginosa mutant TM5 (a-k). The eleven clones were isolated after
the cosmid library screen and showed sensitivity to the phage JG004 infection, which
requires wild type LPS. Shown are 1 % agarose gels after staining with ethidiumbromide.
Cosmid was digested with EcoRI and HindIII. M: Molecular weight marker.
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The phage SZ01 was able to infect the described LPS mutants including the pre-
sented clinical isolates but not the PAO1 wild type. Altogether we could identify 11
complemented clones. The clones were resistant to the phage SZ01 and contained
LPS similar to the wild type PAO1 (data not shown). Moreover, the clones were
sensitive to the LPS specific phage JG004 after complementation. The cosmid was
isolated and analyzed by digestion with restriction enzymes (2.6.8). An identical
restriction pattern indicates that all clones were complemented by the same cosmid
(Fig. 22).
Figure 23: Genomic organization of cosmid insert. The insert has a size of ca. 31 kb
covering the region from 5618374 to 5649292 of the Pseudomonas aeruginosa PAO1
genome. Arrows indicate length and orientation of genes. Altogether the cosmid
insert contains 20 complete genes of the P. aeruginosa PAO1 genome (provided by
www.pseudomonas.com)
To identify the genes of the cosmid insert, sequencing analysis was done using
primers binding to the flanking regions of the multiple clonig site present in cosmid
pLAFR3 (2.6.8). The sequencing results were compared with the www.pseudomonas.
83
3 Results and Discussion
com genome database. The cosmid harbors a 31 kb insert covering a region starting
at 5618374 to 5649292 of the P. aeruginosa genome. The first 13,3 kb including
the genes PA5001 to waaF (PA5012) are part of a probable LPS core biosynthesis
cluster (Fig. 23).
To identify the defect gene in the LPS mutants, each gene of this operon was ampli-
fied by PCR and cloned into a pUCP20T vector for complemen- tation experiments.
Finally, we could identify PA5001 which allowed complementation of LPS mutants.
PA5001 is a uncharacterized probable glycosyltransferase (King et al., 2009). Gly-
cosyltransferases are known to transfer monosaccharides to an acceptor molecule.
Complementation with the gene PA5001 leads to wild type LPS in the transpo-
son mutants TM5 and TM6 and also in the clinical isolate GH06 41910 (Fig. 24).
Moreover, it was not possible to complement the other four clinical isolates with
this gene, but sequence analysis showed several mutations in PA5001.
To confirm our results we constructed a PA5001 deletion mutant and a mexRPA5001
double deletion mutant (2.7). The PA5001 single mutant and the mexRPA500 dou-
ble mutant have a similar LPS pattern as the clinical isolates and the transposon
mutants (Fig. 24). Complementation of the PA5001 and mexRPA5001 deletion
mutant with PA5001 restored wild type LPS (Fig. 24).
To further confirm the oxidative stress resistance phenotype observed in mutants
TM5, TM6 and GH06 41910 (3.2.5) we challenged the PA5001 and mexRPA5001
mutants with menadione as described (2.5.8). Fig. 25 clearly shows that the toler-
ance to menadione in the knockout mutants is comparable to the phenotype of the
transposon mutants and the clinical isolate. PA5001 restored sensitivity to mena-
dione, as abserved for the wild type, in the deletion mutants (Fig. 25) as well as in
the transposon mutants and the clinical isolate GH06 41910 (Fig. 26). This indi-
cates that mutations in PA5001 result in a higher tolerance to oxidative stress. Since
the double mutant mexRPA5001 displays the same phenotype as the PA5001 single
mutant, the gene mexR seems to play no role in this oxidative stress experiment.
Moreover, the MIC for three antibiotics was determined to see if the LPS truncation
contributes to high level antibiotic resistance. I used the antibiotics carbenicillin,
levofloxacin and nalidixic acid and tested the MIC for the wild type PAO1 and the
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Figure 24: Silver stained 16.5 % tricine-SDS gel displaying the truncated LPS after com-
plementation with PA5001 using the plasmid pJG004. Complementation with the gene
PA5001 restored wild type LPS. The LPS was isolated as described in 2.9 and 3 µl of
each LPS preparation was loaded to the gel. The arrows designated A and B indicate the
position of the wild type and truncated LPS, respectively. The LPS components of P.
aeruginosa are indicated. The LPS is composed of the lipid A, the core polysaccharide
and the O-antigen. The LPS of the following P. aeruginosa strains are shown: 1, PAO1;
2, TM5; 3, TM5 complemented with PA5001; 4, TM6; 5, TM6 complemented with
PA5001; 6, GH06 41910; 7, GH06 41910 complemented with PA5001; 8, PA5001 dele-
tion mutant; 9, PA5001 deletion mutant complemented with PA5001; 10, mexRPA5001
deletion mutant; 11, mexRPA5001 deletion mutant complemented with PA5001.
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Figure 25: Survival of different Pseudomonas aeruginosa strains challenged with mena-
dione. P. aeruginosa PAO1 (dash), the P. aeruginosa PA5001 (circles) and the
mexRPA5001 (inverted triangles) deletion mutant after exposure to increasing concen-
trations of menadione. Incubation time was 4 h at 37℃ with a menadione concentration
range of 2.5 mM to 10 mM. After incubation at 37℃ the colony forming unit was deter-
mined by serial dilutions as described in 2.5.4 to calculate the survival rate in percent.
Complementation with PA5001 is represented by the dashed lines
PA5001 deletion mutants as described in Material and Methods (2.5.6). Fig. 27
shows that the MIC for the PA5001 mutant is slighlty increased for all three tested
antibiotics compared to the wild type. These results and the results above indicate
that a mutation in PA5001 has only a marginal effect on the resistance to antibiotics.
But indicates a significant contribution to the survival during oxidative stress.
The gene PA5001 was also found in the work of Schurek et al. (2008) in connec-
tion with aminoglycoside resistance. A PA14 transposon library was used in this
approach to identify mutants with an increased tobramicin resistance. Mutation
in PA5001 was identified to play a role in low-level tobramicin resistance. Since
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Figure 26: Survival of different Pseudomonas aeruginosa strains challenged with mena-
dione. P. aeruginosa PAO1 (dash), the P. aeruginosa transposon mutants TM5
(crosses), TM6 (triangles) and the clinical isolate GH06 41910 (squares) after expo-
sure to increasing concentrations of menadione. Incubation time was 4 h at 37 ℃ with
a menadione concentration range of 2.5 mM to 10 mM. After incubation at 37 ℃ the
colony forming unit was determined by serial dilutions as described in 2.5.4 to calcu-
late the survival rate in percent. Complementation with PA5001 is represented by the
dashed lines
mutations in PA5001 occur in the presence of antibiotics we suggest that the sec-
ondary mutations of the transposon mutants in PA5001 are due to the high antibiotic
concentrations used during the transposon screen.
Moreover, our experiments revealed no direct connection between the mutation in
mexR and PA5001. Both mutations are likely to emerge independently since both
mutations have an impact on the resistance to antibiotics. One mutation leads to the
export of antibiotics and the other to a tolerance to oxidative stress which damages
important cell molecules like the DNA, proteins and also lipids. However, we found
a new mechanism of antibiotic resistance which involves unexpected mutations of
the probable glycosyltransferase PA5001. This finding may play a significant role in
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Figure 27: Minimal inhibitory concentration (MIC) determinations of the wild type PAO1
and the PA5001 deletion mutant. The antibiotics carbenicillin, levofloxacin and nalidixic
acid were used as described in 2.5.6.
the specific adaptation to antibiotic stress and increases our knowledge of antibiotic
resistance mechanisms in P. aeruginosa.
3.2.7 Involvement of OprI in oxidative stress tolerance
I could show that antibiotic treatment leads to mutations in the gene PA5001 which
results in the truncation of the LPS. This truncation increases the tolerance to
oxidative stress. However, the exact mechanism behind the tolerance is unknown.
It was shown before that the lipoprotein OprL of P. aeruginosa helps protect the cell
from oxidative stress (Panmanee et al., 2008). Therefore, we isolated the proteins
from the outer membrane as described in 2.10 to investigate if the truncated LPS
has an impact on the outer membrane proteins and if these proteins contribute to
the oxidative stress tolerance.
The isolated proteins of the wild type PAO1, the mexR as well as the mexRPA5001
and PA5001 deletion mutants were separated via SDS PAGE (Fig. 28). Clearly,
the profiles of the outer membrane proteins look similar exept for a stronger signal
of a band with a size of around 9 kDa in the mexRPA5001 and PA5001 deletion
mutants. Mass spectrometry revealed the presence of lipoprotein OprI in this pro-
tein band which is encoded by the gene PA2853. OprI is a small protein of 8.83
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Figure 28: SDS-PAGE (15 %) of isolated outer membrane proteins. Outer membrane
proteins were isolated, separated and stained as described in 2.10. 50 µg protein was
loaded to the gel for each sample. The arrow indicates the position of the lipoprotein
OprI with a size of approximately 9 kDa. M, Molecular weight marker; 1, PAO1; 2,
P. aeruginosa mexR deletion mutants; 3, P. aeruginosa PA5001 deletion mutant; 4,
P. aeruginosa mexRPA5001 deletion mutant; 5, P. aeruginosa PA5001 deletion mutant
complemented with PA5001; 6, P. aeruginosa mexRPA5001 deletion mutant comple-
mented with PA5001.
kDa which corresponds to the determined molecular mass of the protein band with
a size of approximately 9 kDa in Fig. 28. OprI is one of the major proteins of the
outer membrane in P. aeruginosa and probably functions as a physical link between
the outer membrane and the peptidoglycan (Duchêne et al., 1989). This protein
is highly conserved among different P. aeruginosa strains and therefore used as an
antigen for possible vaccines (Bumann et al., 2010).
Interestingly, complementation of PA5001 in the PA5001 and mexRPA5001 mutant
leads to complete loss of the corresponding protein band (Fig. 28). This indicates
that the truncation of the LPS leads to higher amounts of OprI in the outer mem-
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brane and it is possible that this protein contributes to the oxidative stress tolerance
as it was shown for the lipoprotein OprL. Still, the exact mechanism which helps to
understand the observed tolerance is not completely understood. This mechanism
involves a mutation in PA5001 which probably has other effects like the impact on
the amount of OprI and therefore making this mechanism to a complicated but very
interesting research object.
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The genome sequence and the comprehensive characterization of both phages opens
several interesting questions, which should be addressed in future studies.
Both phages may be suitable for phage therapy, especially their ability to lyse al-
ginate overproducing clinical isolates, rewards further research. It should be tested
if these phages contain alginate degrading enzymes on their surface which would
facilitate infection of mucoid strains.
Moreover, the low similarity to other phages makes JG004 an interesting research
topic. Only few genes encoding for proteins of the phage particle were found.
Isolation of the phage capsid and characterization of these proteins would help to
find the corresponding genes. A probable endolysin was detected in JG004 due to
sequence similarities which has to be proved experimentally. Finally, the depen-
dence of phage JG004 on spermidine produced by the host bacterium has to be
investigated in more detail.
We could show that mutations in the uncharacterized probable glycosyltransferase
PA5001 emerge due to antibiotic stress. Unexpectedly, the mutation helps protect
the cells from oxidative stress which are induced by antibiotics. Still, the interesting
mechanism behind the tolerance is unknown and has to be investigated. The possible
involvement of the lipoprotein OprI in this mechanism was discussed but is not
completely understood yet. A gene deletion of the corresponding gene would unravel
the involvement of OprI. Further research could also address the cytotoxicity of the
truncated LPS.
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Figure 29: The sequence of the 12 tRNAs of JG004 in cloverleaf structure.
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Table 18: Codon Usage of P. aeruginosa, phage JG004 and JG024. * = stop codon.
Codon Amino acid P. aeruginosa JG004 JG024
frequency/acid (%) frequency/acid (%) frequency/acid (%)
GCU alanin 4.14 40.3 16.98
GCG alanin 33.41 12.48 27.4
GCC alanin 58.27 23.16 41.73
GCA alanin 4.17 24.06 13.89
AUC isoleucine 90.87 52.5 68.47
AUA isoleucine 2.27 8.11 8.13
AUU isoleucine 6.86 39.39 23.4
UAU tyrosine 20.78 40.48 52.22
UAC tyrosine 79.22 59.52 47.78
UGU cysteine 10 36.36 23.53
UGC cysteine 90 63.64 76.47
CAU histidine 28.95 39.58 35.39
CAC histidine 71.05 60.42 64.61
GUU valine 3.94 29.81 21.12
GUG valine 48.49 22.57 25.61
GUC valine 41.78 20.04 39.96
GUA valine 5.78 27.58 13.32
CGU arginine 10.41 22.29 12.87
CGG arginine 18.49 14.78 17.13
CGC arginine 64.72 14.78 42.56
CGA arginine 3.11 17.11 12.79
AGG arginine 2.64 13.16 7.6
AGA arginine 0.62 17.89 7.05
UAG * 11.45 8.13 6.38
UAA * 9.45 55 43.62
UGA * 79.1 36.86 50
UGG tryptophan 100 100 100
CAG glutamine 85.3 48.11 67.51
CAA glutamine 14.7 51.89 32.49
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Codon Amino acid P. aeruginosa JG004 JG024
frequency/acid (%) frequency/acid (%) frequency/acid (%)
AAU asparagine 14.18 35.75 32.4
AAC asparagine 85.82 64.25 67.57
UCU serine 1.51 25.25 14.13
AGU serine 4.77 15.05 8.10
UCG serine 23.66 15.11 23.87
UCC serine 21.89 15.05 26.17
AGC serine 47.11 24.31 22.16
UCA serine 1.06 5.23 5.58
AAA lysine 12.53 41.64 36.37
AAG lysine 87.47 58.36 63.63
CUU leucine 2.49 19.37 12.01
UUG leucine 7.03 14.26 15.31
UUA leucine 0.23 2.79 1.49
CUG leucine 66.77 29.08 44.84
CUC leucine 22.36 15.88 22.13
CUA leucine 1.13 18.63 4.22
CCU proline 4.18 37.49 18.68
CCG proline 65.77 28.24 52.44
CCC proline 25.76 13.44 14.65
CCA proline 4.29 20.84 14.23
GAU aspartic acid 19.70 42.56 44.08
GAC aspartic acid 80.3 57.44 55.92
ACU threonine 3.97 36.12 23.73
ACG threonine 15.24 12.4 20.15
ACC threonine 78.84 27.09 48.96
ACA threonine 1.95 24.39 7.16
UUU phenylalanine 4.85 23.46 15.74
UUC phenylalanine 95.15 76.54 84.26
GAG glutamic acid 61.46 51.79 43.85
GAA glutamic acid 38.54 48.21 56.15
AUG methionine 100 100 100
GGU glycine 9.81 29.27 16.93
GGG glycine 11.75 16.45 13.39
GGC glycine 73.51 28.6 52.48
GGA glycine 4.93 25.68 17.2
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Table 19: The genes of phage JG004 and their predicted function. HP = Hypothetical protein.
ORF From To Length Length Predicted function Identity e-value
(bp) (aa) (Protein superfamily) (aa identity)
1 96 224 129 42 HP HP of Enterobacteria phage WV8 (20/36) 2.0
2 295 543 249 82 HP
3 540 827 288 95 HP
4 827 1138 312 103 HP
5 1338 1811 474 157 HP (DUF335) HPEnterobacteria phage RB43 (32/37) 9e-10
6 1837 2001 165 55 HP
7 2440 2613 174 57 HP
8 2836 3822 987 328 HP HP Clostridium difficile (67/233) 1e-9
9 3991 4242 252 83 HP
10 4254 4493 240 79 HP
11 4495 4689 195 64 HP
12 4699 5202 504 167 HP
13 5222 5488 267 88 HP
14 5677 5991 315 104 HP
15 5991 6227 237 78 HP
16 6227 6460 234 77 HP
17 6460 6708 249 82 HP
18 6905 8650 1746 581 putative ribonucleotide NrdA Aeromonas 3e-100
reductase (RNR PFL) phage 31 (211/567)
19 8643 9689 1047 348 HP (Ferritin like) HP Pseudomonas phage PA11 (118/314) 4e-52
20 9719 10063 345 114 HP HP Enterobacteria phage Felix01 (32/83)
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ORF From To Length Length Predicted function Identity e-value
(bp) (aa) (Protein superfamily) (aa identity)
21 10066 11013 948 315 putative thymidylate thymidylate synthase 6e-77
synthase (Thy1) Escherichia phage rv5 (158/325)
22 11220 12170 951 316 HP HP Burkholderia ambifaria phage
BcepF1 (41/76)
23 12163 12375 213 70 HP
24 12379 12714 336 111 HP
25 12733 12939 207 68 HP
26 12967 13149 183 60 HP HP Burkholderia oklahomensis EO147 (24/56) 0.9
27 13146 13925 780 259 HP constituent protein Pseudomonas 7e-44
phage PaP3 (99/235)
28 13922 14173 252 83 HP
29 14106 14276 171 56 HP
30 14273 14710 438 145 HP
31 14707 14913 207 68 HP
32 14934 15332 399 132 HP HP Psychroflexus torquis (33/127) 0.001
33 15329 15892 564 187 HP HP Enterobacteria phage phiEcoM-GJ1 (61/171) 2e-20
34 15889 16941 1053 350 putative putative exodeoxyribonuclease 1e-30
exodeoxyribonuclease Escherichia phage rv5 (102/374)
35 16983 17204 222 73 HP
36 17214 17447 234 77 HP
37 17517 18521 1005 334 HP
38 18623 19339 717 238 HP
39 19537 19935 399 132 HP
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40 20025 22739 2715 904 putative DNA polymerase DNA polymerase Escherichia 1e-44
(DNA pol A) phage rv5 (152/548)
41 22800 24653 1854 617 putative DNA primase/helicase primase/helicase Roseobacter 9e-41
(TOPRIM; P loop NTPase) phage SI01 (140/508)
42 24715 24901 186 61 HP
43 24898 25143 246 82 HP
44 25619 25915 297 98 HP
45 26012 26314 303 100 HP
46 26317 26481 165 54 HP
47 26468 27124 657 218 HP (PRK11409) HP Rhizobium etli 8C-3 (26/82) 0.013
48 27121 27663 543 180 HP HP Ralstonia pickettii12J (24/86) 0.004
49 27802 28287 486 161 HP
50 28299 28496 198 65 HP
51 28497 28691 195 64 HP
52 28804 28947 144 47 HP
53 28937 29170 234 77 HP
54 29208 29441 234 77 HP
55 29472 30608 1137 378 putative RNA ligase putative RNA ligase Pseudomonas 1e-44
phage 20phi2-1 (151/466)
56 30611 30766 156 51 HP
57 30759 31568 810 269 HP gp06 Burkholderia phage BcepMu (58/100) 1e-22
58 31570 31890 321 106 HP
59 31901 32209 309 102 HP
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60 32605 32910 306 101 HP HP Pseudomonas aeruginosa PACS2 (20/49) 1.1
61 32900 33031 132 43 HP
62 33048 33485 438 145 HP HP Clostridium sp. (33/134) 0.33
63 33472 33711 240 79 HP
64 33729 34289 561 186 putative peptidoglycan putative peptidoglycan binding protein 2e-50
binding protein Pseudomonas aeruginosa (101/189)
65 34306 35805 1500 499 HP phage protein Enterobacteria phage phiEcoM-GH1 (32/88) 4e-6
66 35819 36193 375 124 putative tail fiber putative tail fiber protein prophage 0.005
protein Pseudomonas syringae (23/65)
67 36237 38294 2058 685 putative tail fiber putative tail fiber protein 3e-6
protein Aggregatibacter phage S1249 (36/98)
68 38305 39036 732 243 HP HP Haemophilus phage Aaphi23 (41/110) 2e-12
69 39055 40518 1464 487 putative baseplate putative baseplate component 7e-31
component Erwinia phage phiEa21-4 (128/481)
70 40520 40891 372 123 HP HP Iodobacteriophage phiPLPE (38/108) 5e-10
71 40902 41642 741 246 putative baseplate putative baseplate protein 3e-8
protein (DUF586) Haemophilus phage Aaphi23 (39/129)
72 41639 42556 918 305 HP HP Pseudomonas fluorescens PF0-1 (117/304) 3e-54
73 42553 42909 357 118 HP HP Ralstonia pickettii 12D (21/89) 0.024
74 42915 43676 762 253 HP HP Pseudomonas fluorescens PF0-1 (90/231) 1e-39
75 43673 46039 2367 788 putative tape measure tape measure protein 8e-19
protein (COG3941) Burkholderia phage BcepNazgul (69/217)
76 46036 46188 153 50 HP
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77 46296 46667 372 123 HP
78 46681 47160 480 159 HP HP Kingella oralis ATCC 51147 (48/145) 1e-7
79 47160 47633 474 157 HP Haemophilus influenzae 86-028NP (36/96) 2e-13
80 47735 48259 525 174 HP HP Bordetella petrii DSM 12804 (51/146) 3e-13
81 48272 49048 777 258 putative endonuclease endonuclease SegD Vibrio 4e-12
(GIY-YIG) phage KVP40 (50/110)
82 49107 50393 1287 428 putative structural protein structural protein Erwinia phage 3e-39
phiEa21-4 (132/450)
83 50406 50969 564 187 putative methyltransferase cysteine methyltransferase Geobacillus 0.23
sp. G11MC16 (32/104)
84 50966 51346 381 126 HP HP Haemophilus influenzae 22.4-21 (37/119) 0.015
85 51346 51759 414 137 putative RNA polymerase putative RNA polymerase 1e-4
Xanthomonas phage OP2 (44/130)
86 51797 52273 477 158 HP HP Erwinia phage phiEa21-4 (42/129) 1e-12
87 52323 53357 1035 344 HP bacteriophage-related protein 4e-41
Rhodobacter sphaeroides (116/345)
88 53402 53812 411 136 HP
89 53840 54757 918 306 HP HP Escherichia phage rv5 (31/111) 1e-6
90 54754 55224 471 156 putative methyltransferase N6 adenine-specific DNA 4e-10
methyltransferase Haliangium ochraceum (45/137)
91 55234 56673 1440 479 HP HP Enterobacteria phage WV8 (191/486) 6e-102
(DUF935)
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92 56686 58206 1521 506 putative terminase putative terminase Erwinia phage 2e-83
(COG5362) phiEa21-4 (191/458)
93 58328 58609 282 93 HP
94 58811 59110 300 99 HP
95 59485 59589 105 34 HP
96 60645 60827 183 60 HP
97 60897 61220 324 107 HP
98 62012 62479 468 155 HP aminotransferase Rhodobacterales 0.023
bacterium HTCC2654 (21/71)
99 62476 62832 357 118 HP HP Pseudomonas aeruginosa PA14 (28/108) 0.017
100 62880 63428 549 182 putative protease ClpP ATP-dependent protease subunit 1e-9
subunit (Clp protease like) Escherichia phage rv5 (52/161)
101 63489 63674 186 61 HP
102 63671 63964 294 97 HP Orf41 Pseudomonas phage D3 (35/53) 2e-12
103 64031 64463 432 143 HP
104 64460 64738 279 92 HP HP Campylobacter gracilis RM3268 (21/58) 0.27
105 64752 65066 315 104 HP
106 65068 65727 660 219 putative HNH HNH endonuclease 6e-7
endonuclease (AP2) Bacteriophage T5 (39/92)
107 65736 66005 270 89 HP
108 66002 66214 213 70 HP HP Enterobacteria phage EcoDS1 (28/69) 2e-8
109 66224 66460 237 78 HP
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110 66463 66879 417 138 putative deoxycytidylate deoxycytidylate deaminase 7e-20
deaminase (cytidine deaminase like) Bacteroides vulgatus (54/123)
111 66876 68084 1209 402 putative DNA ATP-dependent DNA ligase 9e-32
ligase (DNA ligase AM) Escherichia phage rv5 (128/417)
112 68097 68561 465 154 HP
113 68619 69179 561 186 putative cell wall cell wall hydrolase SleB 3e-18
hydrolase (Hydrolase 2) Methylobacterium populi BJ001 (59/134)
114 69181 69741 561 185 putative phosphohydrolase Metal dependent phosphohydrolase 9e-11
Lentisphaera araneosa (51/151)
115 69731 70162 432 143 putative hydrolase hydrolase protein Cardiobacterium hominis (14/22) 0.069
116 70162 70716 555 184 putative phosphoesterase phosphoesterase 3e-29
(PP2Ac) Chryseobacterium gleum (76/188)
117 70729 70965 237 78 HP
118 70967 71242 276 91 HP HP Kingella oralis (21/58) 2e-5
(COG5606)
119 71239 71646 408 135 HP HP Enterobacteria phage JS98 (46/161) 9e-5
120 71658 72575 918 305 putative RNA ligase/tail RNA ligase 1 and tail attachment protein 3e-43
attachment protein (RNA lig T4 1) Escherichia phage rv5 (120/304)
121 72586 73005 420 139 HP HP Escherichia phage rv5 (54/133) 3e-21
122 73015 73890 876 291 putative ribose-phosphate putative ribose-phosphate pyrophosphokinase 4e-34
pyrophosphokinase (Pribosyltran) Enterobacteria phage Felix 01 (97/264)
123 73945 74163 219 72 HP
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124 74162 75850 1689 562 putative nictotinate phospho- putative nictotinate phosphoribosyltransferase 4e-99
ribosyltransferase (PRTase type II) Enterobacteria phage WV8 (238/594)
125 75862 76059 198 65 HP
126 76056 76535 480 159 HP HP Acinetobacter phage 133 (66/160) 2e-21
(Macro Poa1p like)
127 76547 76696 150 49 HP
128 76880 77587 708 235 HP HP Aeromonas phage 25 (79/194) 5e-29
129 77664 77975 312 103 HP
130 77962 78465 504 167 HP HP Pseudomonas fluorescens Pf0-1 (44/144) 3e-10
131 78467 78808 342 113 HP
(P-loop NTPase)
132 79052 79438 387 128 HP HP Pseudomonas phage LIT1 (31/117) 0.017
133 79438 79749 312 103 HP
134 79737 80015 279 92 HP
135 80018 80719 702 233 HP
136 80736 81158 423 140 HP
137 81148 81552 405 134 putative homospermidine homospermidine synthase (34/101) 0.32
synthase Cupriavidus taiwanensis
138 81552 81818 267 88 HP
139 81872 82030 159 52 HP
140 82307 82450 144 47 HP
141 82550 83203 654 217 HP HP Listonella phage phiHSIC (49/162) 2e-6
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142 84381 84575 195 64 HP HP LMA2 (59/64) 5e-27
143 84673 84939 267 88 HP
144 85342 85731 390 130 HP
145 86047 86328 282 93 HP
146 86328 86807 480 159 HP HP Proteus vulgaris (35/108) 6e-5
147 86942 87421 480 159 HP HP Pseudomonas phage 201phi2-1 (37/123) 4e-4
148 87457 88098 642 213 HP
149 88121 88702 582 193 HP HP Erwinia phage phiEa21-4 (66/193) 9e-14
150 88817 89209 393 130 HP
151 89206 89472 267 88 HP
152 89505 89729 225 74 HP
153 89726 90022 297 98 HP
154 90040 90234 195 64 HP
155 90231 90503 273 90 HP
156 90500 90868 369 122 HP
157 90868 91206 339 112 HP
158 91211 91834 624 207 HP HP Cyanophage P-SSP7 (92/233) 3e-40
159 91958 92341 384 127 HP
160 92334 92633 300 100 HP
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1 25 327 303 100 HP HP of phage 14-1 (96/100) 6e-48
2 383 556 174 57 HP HP of phage SN (56/57) 3e-25
3 607 753 147 48 HP HP of phage SN (48/48) 5e-17
4 802 2313 1512 503 terminase, large subunit terminase of SN (458/460) 0.0
(DUF1545; terminase 3)
5 2350 2733 384 127 HP HP of phage 14-1 (127/127) 7e-67
6 2730 2948 219 72 HP HP of phage 14-1 (72/72) 4e-35
7 2948 3298 351 106 HP HP of phage LBL3/14-1 (106/106) 2e-54
8 3344 3745 402 133 HP HP of phage 14-1 (132/133) 7e-69
9 3748 4527 780 259 HP HP of phage 14-1 (259/259) 1e-151
10 4614 5111 498 165 HP HP of phage SN (143/145) 2e-75
11 5068 5655 588 195 HP HP of phage LBL3/14-1 (195/195) 6e-113
12 5757 6689 933 310 HP HP of phage 14-1 (310/310) 0.0
13 6792 7292 501 166 HP (NADB Rossmann) HP of phage 14-1 (165/165) 3e-93
14 7312 7659 348 115 HP HP of phage 14-1 (114/115) 5e-59
15 7908 8453 546 181 HP HP of phage F8 (153/181) 8e-84
16 8425 8748 324 107 HP HP of phage SN (105/107) 4e-57
17 8780 9181 402 133 HP HP of phage LMA2 (133/133) 8e-72
18 9362 11659 2298 765 minor head protein minor head protein phage 14-1 (748/765) 0.0
(Phge rel HI1409; DUF2212)
19 11659 12495 837 278 putative minor head protein putative minor head protein phage 3e-157
(Phage Mu F) LMA2 (268/278)
20 12515 12721 207 68 HP HP of phage LBL3 (68/68) 2e-31
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21 12718 12858 141 46 HP HP of phage SN (44/46) 2e-16
22 13370 14806 1437 478 putative structural protein putative structural protein phage LMA2 0.0
(DUF2213) (461/478)
23 14810 15445 636 211 putative structural protein structural protein phage SN (211/211) 1e-115
24 15455 16603 1149 392 putative major structural protein putative major structural protein 0.0
phage LMA2 (379/382)
25 16705 17142 438 145 HP HP of phage SN (143/145) 8e-80
26 17157 17624 468 155 putative structural protein putative structural protein phage LMA2 (155/155) 1e-85
27 17648 18019 372 123 putative structural protein structural protein phage SN (123/123) 8e-66
(PHA02310)
28 18027 18578 552 183 HP HP of phage LMA2 (183/183) 2e-104
29 18575 19156 582 193 HP HP of phage F8 (193/193) 3e-107
30 19260 20687 1428 475 putative structural protein putative structural protein 0.0
phage PB1 (468/475)
31 20746 21198 453 150 putative structural protein putative structural protein phage LMA2 (147/150) 2e-79
32 21294 21521 228 75 putative structural protein putative structural protein phage LMA2 (75/75) 4e-38
33 21518 21868 351 116 putative structural protein putative structural protein phage LMA2 (116/116) 1e-60
34 21870 22301 432 143 HP HP of phage SN (141/143) 1e-71
35 22311 22814 504 167 putative structural protein structural protein phage SN (167/167) 7e-90
36 22949 23353 405 134 putative structural protein putative structural protein phage LMA2 (134/134) 2e-73
37 23222 23353 132 43 putative structural protein putative structural protein phage LMA2 (43/43) 2e-16
38 23362 23955 594 197 putative structural protein structural protein phage SN (180/183) 1e-87
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39 23965 24393 429 142 HP HP of phage LBL3 (142/142) 1e-78
40 24397 26973 2577 858 putative lytic tail protein putative lytic tail protein 0.0
(lysozyme like) phage LMA2 (858/858)
41 26973 27836 864 287 putative structural protein putative structural protein phage LMA2 (284/287) 1e-165
42 27836 28369 534 177 HP HP of phage 14-1 (176/177) 7e-99
43 28425 29090 666 221 putative baseplate protein putative baseplate protein phage SN (217/221) 7e-124
44 29101 30399 1299 432 putative baseplate protein putative baseplate protein 0.0
(baseplate J) phage SN (432/433)
45 30396 31910 1515 504 putative structural protein putative structural protein phage LBL3 (500/504) 0.0
46 31915 34803 2889 964 putative tail fiber protein putative tail fiber protein phage SN (904/962) 0.0
47 34805 35233 429 142 putative tail fiber component putative tail fiber component phage PB1 (133/142) 4e-72
48 35233 35895 663 220 putative endolysin putative endolysin phage LMA2 (217/220) 6e-126
(lysozyme like)
49 35920 36171 252 83 HP HP of phage 14-1 (83/83) 1e-38
50 36451 37362 912 303 putative DNA ligase putative DNA ligase phage SN (299/303) 7e-177
(DNA ligase A M)
51 37417 37971 555 184 HP HP of phage 14-1 (179/184) 4e-100
(DUF 2166)
52 37968 38573 606 201 HP HP of phage F8 (201/201) 1e-108
53 38627 39523 897 298 HP HP of phage 14-1 (297/299) 3e-163
54 39612 40232 621 206 HP HP of phage LMA2 (206/206) 1e-113
55 40327 41886 1560 519 putative helicase putative helicase phage LBL3 (509/519) 0.0
(P-loop NTPase)
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56 41883 42293 411 136 putative DNA helicase putative DNA helicase phage SN (136/136) 1e-73
57 42286 45393 3108 1035 putative DNA polymerase III alpha putative DNA polymerase III alpha 0.0
subunit (DNA pol3 alpha) subunit phage SN (1030/1035)
58 45393 45947 555 183 putative DNA polymerase III putative DNA polymerase III epsilon 4e-104
epsilon subunit (DnaQ like exo) subunit phage LMA2 (181/184)
59 46023 47039 1017 388 HP HP of phage 14-1 (337/338) 0.0
60 47042 47380 339 112 HP HP of phage LMA2 (63/63) 6e-28
61 47235 48152 918 305 putative thymidylate synthase putative thymidylate synthase 0.0
(Thy1) phage LBL3 (301/305)
62 48152 48358 207 68 HP HP of phage 14-1 (68/68) 2e-31
63 48366 48596 231 76 HP HP of phage SN (76/76) 2e-37
64 48629 48790 162 53 HP HP of phage SN (53/53) 3e-24
65 48831 49049 219 72 HP HP of phage LBL3 (71/72) 4e-32
66 49049 49279 231 76 HP HP of phage 14-1 (76/76) 4e-38
67 49367 50368 1002 303 HP HP of phage 14-1 (333/333) 0.0
68 50473 51357 885 294 putative structural protein putative structural 2e-88
protein phage LMA2 (277/293)
69 51519 52706 1188 395 putative ATP-dependent putative ATP-dependent exonuclease V 0.0
exonuclease V (P-loop NTPase) phage SN (395/395)
70 52693 53115 423 140 HP HP of phage 14-1 (138/140) 2e-75
71 53284 54069 786 261 HP HP of phage 14-1 (260/261) 8e-150
72 a 53996 55084 1089 362 HP HP of phage 14-1 (312/314) 0.0
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72 b 55201 55383 183 60 HP HP of phage 14-1 (60/60) 6e-29
73 55407 55856 450 149 HP HP of phage 14-1 (147/149) 6e-82
74 55853 56929 1077 358 HP HP of phage 14-1 (357/358) 0.0
75 56935 57120 186 61 HP HP of phage LMA2 (61/61) 2e-25
76 57268 59007 1740 579 putative primase putative primase phage LMA2 (573/579) 0.0
(COG5545)
77 59205 59786 582 193 HP HP of phage F8 (116/146) 1e-57
78 59800 59931 132 43 HP no
79 59977 60546 570 189 HP HP of phage 14-1 (189/189) 1e-107
80 60714 61325 612 203 HP HP of phage 14-1 (203/203) 2e-112
81 61515 62210 696 231 HP HP of phage 14-1 (231/231) 3e-130
82 62221 62532 312 103 HP HP of phage 14-1 (103/103) 5e-56
83 62585 62806 222 74 HP HP of phage 14-1 (73/73) 1e-33
84 62791 63072 282 93 HP HP of phage 14-1 (63/63) 6e-28
85 63123 63347 225 74 HP HP of phage LBL3 (74/74) 5e-36
86 63413 63739 327 108 HP HP of phage LBL3 (108/108) 8e-57
87 63740 64582 843 280 HP HP of phage 14-1 (211/214) 2e-120
88 64416 64625 210 69 HP HP to phage 14-1 (69/69) 4e-34
89 64622 64837 216 71 HP HP of phage 14-1 (69/71) 2e-32
90 64834 65058 225 74 HP HP of phage LBL3 (64/66) 3e-30
91 65031 65282 252 83 HP HP to phage LBL3 (80/83) 1e-40
92 65368 65541 174 57 HP HP of phage LMA2 (41/57) 4e-19
93 65559 66245 687 228 HP HP of phage SN (147/226) 2e-78
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